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1. INTRODUCTION 
Diabetes mellitus has emerged as one of the most rampant metabolic disorders in the 
past century owing to multiple social, genetic and lifestyle factors. The effects of 
diabetes mellitus on the human body are numerous and multiple hypotheses have 
been proposed to explain these effects at a molecular level.  
India has also seen a steady rise in the number of people diagnosed with diabetes 
mellitus or those who present with complications secondary to diabetes. Of 
significant interest and research is the effect of diabetes on the blood flow, both at the 
macrovascular level and microvascular level. One of the most debilitating 
complication secondary to diabetes mellitus is the development of diabetic ulcers and 
subsequently the need for amputation. Amputation of any kind accounts for 
considerable morbidity and alteration in the quality of life. Hence, there is an 
imminent need to screen and identify individuals at risk for developing complications 
in the foot secondary to diabetes.  
A gamut of options are available to indirectly assess the blood flow to different parts 
of the body, each with its own advantages and limitations. One such modality is the 
use of photoplethysmography which has until now been widely used for 
characterising various physiological parameters like blood pressure, heart rate and 
respiratory rate.  
To explore the use and application of photoplethysmography in assessing the blood 
flow to the foot is the primary objective of this study.  It would facilitate the 
identification of areas of the foot at risk for ulceration and other changes secondary 
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to diabetes mellitus. This could potentially pave the path for developing appropriate 
footwear or other offloading devices to curtail the progression of the disease. This 
may hopefully decrease the need for amputations, thereby resulting in a better quality 
of life.  
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2. AIM AND OBJECTIVES 
AIM 
To study the role of multipoint contact photoplethysmography in assessing the 
changes in blood flow in the plantar aspect of the contralateral foot following 
amputation in diabetic patients. 
 
OBJECTIVES 
Primary: To determine the peak amplitudes and peak times using 
photoplethysmography (photoplethysmograph) waveforms as a measure of changes 
in blood flow in the plantar aspect of contralateral foot in diabetic patients following 
amputation. 
 
Secondary:  
1. To compare the changes in blood flow over the plantar aspect of the foot in 
diabetic patients with age and gender matched normal subjects. 
2. To map the variations in blood flow over the plantar aspect of the foot and 
therefore identify areas of early microvascular changes in the foot. 
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Null hypothesis 
There are no variations in the photoplethysmography waveforms over the plantar 
aspect of the contralateral foot in diabetic patients following amputation. 
 
Alternate Hypothesis 
There are early microvascular changes in the feet of diabetic patients that can be 
assessed with the principle of photoplethysmography. 
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3. REVIEW OF LITERATURE 
Diabetes mellitus has found its place in the global platform as one of the most rapidly 
emerging diseases. According to the diabetes IDF atlas, the global burden of diabetes 
mellitus in 2017 was approximately 451 million (1).  
There are two broadly accepted types of diabetes mellitus – type I and type II. Type 
II diabetes mellitus is more common in the adult population.  Diabetes mellitus has a 
multifactorial etiology. There is an interplay between impaired insulin secretion and 
insulin resistance which ultimately results in skewed insulin homeostasis in the body 
(2).  
Uncontrolled type II diabetes mellitus is associated with multiple complications 
which can affect different parts of the body. These can be either microvascular or 
macrovascular (3). Microvascular complications encompass diabetic nephropathy, 
neuropathy, retinopathy. Macrovascular complications include risk of 
cerebrovascular disease, coronary artery disease and peripheral arterial disease. 
3.1 PATHOPHYSIOLOGY AND MICROENVIRONMENT IN DIABETES 
MELLITUS  
The effect of diabetes on the foot is the result of a complex interaction between 
microangiopathy and neuropathy which are co-dependent factors.  
The important factors affecting microcirculation include the following: 
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1. Local homeostasis regulated by the autonomic nervous system- This refers to 
the sympathetic and parasympathetic nerve fibres innervating the arterioles 
and capillaries which ultimately regulate the amount of blood flow in the foot. 
2. Effect of gravity and posture on the sympathetic tone- In the standing position 
there is pooling of blood in the lower extremities. There is an increase in 
hydrostatic pressure which causes higher venous pressures. This triggers the 
venoarterial reflex causing sympathetic vasoconstriction (4). It is a local axon 
mediated reflex which causes precapillary vasoconstriction in response to high 
venous pressures in the orthostatic position.  
3. Metabolic factors- Chronic hyperglycemia causes the activation of multiple 
intracellular signalling pathways which results in formation of glycation end 
products, release of harmful reactive oxygen species, polyol formation, 
decreased angiogenesis and recruitment of immune cells for wound healing. 
These ultimately damage the endoneurium of nerve fibres (5).  
4. Endothelial factors- The endothelium releases several cytokines, growth 
factors and neurotransmitters which regulate blood flow. For example- 
acetylcholine, prostaglandins, endothelin, histamine and bradykinin released 
from the endothelium cause vasoconstriction whereas nitric oxide, 
prostacyclin and endothelium-derived hyperpolarizing factor result in  
vasodilation (6).  
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3.2 ANATOMY OF THE SKIN AND MICROVASCULATURE 
The skin has two distinct layers: 
1. The epidermis  
2. The dermis which is further broadly divided into 
• Papillary dermis which is superficial 
• Reticular dermis which is deep 
 
 
 
Figure 1. Anatomy of the microvasculature of the skin. (A) shows the dermal layer 
of the skin where the upper capillary loops are nutritive and the lower capillary loops 
form arteriovenous shunts which are involved in thermoregulation. (B) shows a 
dermal papilla with a single capillary loop (6)  
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It is shown that 80-90 percent of the blood flow in the skin is through the deeper 
arteriovenous shunts and only 10-20 percent is through the superficial nutritive 
capillary layer (7).  
Arteriovenous shunts are low resistance systems which allow flow of blood freely 
between arterioles and venules. These shunts are innervated by the 
adrenergic(sympathetic) and cholinergic(parasympathetic) nerve fibres. These 
arteriovenous shunts are numerous in the glabrous (non hairy) skin and sparse in the 
non glabrous (hairy) areas (8). In a neutral environment, the sympathetic tone 
predominates and keeps the microvasculature in a vasoconstrictive state.  
In patients with diabetes mellitus, neuropathic changes occur in the foot. These 
neuropathic changes cause a disruption of the normal sympathetic tone of the 
vasculature in the foot. This corroborates the finding that in diabetics there is an 
apparent increase in the local blood flow of the foot. The arteriovenous shunts are 
opened up due to the loss of normal sympathetic vasoconstrictive effect (9).  This has 
also been termed as ‘capillary steal’ because the blood is shunted from the nutritive 
capillaries of the skin to the underlying arteriovenous shunts thereby depriving the 
skin of its nutrition. This predisposes the skin to ulceration and delayed wound 
healing.  
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Figure 2. Normal vasculature of the foot (8) 
 
 
Figure 3. Loss of sympathetic tone and opening up of arteriovenous shunts in patients 
with diabetes mellitus (8) 
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Parving et al elucidated the hemodynamic hypothesis of diabetic microangiopathy 
which stated that in early diabetes there is an increase in the microvascular blood flow 
in the capillaries and arterioles (10). It occurs due to direct damage caused by polyols 
and advanced glycation end (AGE) products in hyperglycaemic states. There is a 
decrease in peripheral arterial resistance which causes increased blood flow through 
the arterioles and capillaries. This apparent increase in the blood flow has a 
detrimental effect on the vascular endothelial basement membrane. In response to the 
raised local blood flow there are shearing forces acting on the endothelial surfaces 
which results in an inflammatory response. This results in enhanced permeability of 
the basement membrane causing aggregation of various extracellular matrix proteins 
and over a period of time contributing to arteriosclerosis. There is also a decrease in 
the size of the capillary with pericyte degeneration (11). These arteriolar basement 
membrane changes prevent the microvasculature from appropriately dilating in 
response to increased demands, i.e., loss of normal reactive hyperemia. 
This increase in the blood flow through the arteriovenous shunts can also lead to 
subclinical edema of the foot. 
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3.3 CONVENTIONAL METHODS OF ASSESSING MICROVASCULAR 
CHANGES IN DIABETICS 
Early microvascular changes are present in the feet of diabetic patients which 
contributes to the aetiology of diabetic ulcers, vascular compromise and need for 
amputations. Many investigatory modalities have been proposed to assess these 
microvascular changes which include ankle brachial index (ABI), toe-brachial index 
(TBI), toe pressures, transcutaneous oxygen pressure (TcPO2) and laser doppler 
flowmetry. 
 
 3.3.1ANKLE BRACHIAL INDEX 
The ankle brachial index is widely used as a tool to assess the blood supply to the 
lower limb. It has been used in the diagnosis of peripheral vascular disease. 
Calculation of ankle brachial pressure index involves the following steps(12) 
• Measuring systolic pressure across the brachial artery of both upper limbs 
• Measuring systolic pressure across dorsalis pedis artery of each lower limb 
• Measuring systolic pressure across posterior tibial artery of each lower limb 
• Ratio of highest ankle pressure(across dorsalis pedis or posterior tibial) to the 
highest brachial pressure gives the Ankle Brachial pressure index 
An ankle brachial index of ≤ 0.90 mmHg is generally indicative of peripheral arterial 
disease (13). ABPI of <0.4 is associated with severe peripheral arterial disease and 
increased incidence of gangrene, need for amputations and delayed wound healing.  
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An ABPI of >1.3 is seen when the vessels become hardened or incompressible. This 
is  seen especially in patients with diabetes mellitus where there is calcification of the 
tunica media layer of the arteries. This can also be present in the elderly and those 
with chronic renal disease. Hence in diabetics, ABPI becomes unreliable as a 
diagnostic tool (14). ABPI is a poor indicator of the microvascular changes occurring 
in the foot because the measurements in ABPI are taken proximal to the ankle (15). 
In such patients where the ankle brachial index is unreliable, toe brachial index or toe 
pressures have been used. The toe brachial index is the ratio between the systolic 
pressure measured at the hallux and the brachial systolic pressure. The toe brachial 
index can be considered a better indicator of distal perfusion but there is a  
concomitant broad range of error when utilizing a manual sphygmomanometer and 
handheld Doppler to measure toe systolic pressure (15). 
3.3.2 TOE PRESSURE 
Toe pressures have also been used as an indirect means to measure blood flow across 
the foot. They are considered more representative of the microcirculation of the foot 
when compared to ankle brachial pressure index. Toe pressures less than 30mm of 
mercury are an indicator of poor wound healing in patients with diabetic foot. Toe 
pressures can be measured using various methods. The commonly used method 
involves placing a cuff around the first toe (16). A photoplethysmograph probe is 
then placed over the pulp of the first toe which identifies the blood flow in the 
particular area and represents them as waveforms. The cuff is inflated until there is 
disappearance of the waveform. The cuff is further inflated to about 20mm above this 
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pressure. Then the cuff is slowly deflated until there is return of the waveform. The 
cuff pressure at which the first systolic peak reappears is taken as the toe pressure(17).  
3.3.3 TRANSCUTANEOUS OXYGEN TENSION  
Transcutaneous oxygen tension is another noninvasive method to assess tissue 
perfusion. The TcPO2 is an indirect measurement of the partial pressure of arterial 
oxygen (PaO2) and does not reflect oxygen delivery or oxygen content(18). The basic 
principle involved is the placement of sensors over an area of skin which causes a 
local rise in temperature (37 degree Celsius to 45 degree Celsius ). This rise in 
temperature causes enhanced flow of oxygen in the nutritive capillaries which can 
then be assessed by the TcPo2 sensors.  In comparison to other microvascular 
assessments, TcPO2 is relatively time consuming and cumbersome. It takes about 30 
minutes or longer as the electrode requires at least 15 minutes to warm up and the 
sensors require calibration(19). It is also argued that the measurements of TcPO2 are 
not accurate and reliability of results is equivocal. Callosities or thickening of the 
skin, edema of the limbs can result in falsely decreased TcPO2 values. There can also 
be falsely increased values due to patient movement and increased capillary flow. 
 
3.3.4 LASER DOPPLER FLOWMETRY 
This is another method of assessing the perfusion of the skin. Laser doppler 
flowmetry (LDF) uses monochromatic wavelength of light which is scattered by the 
moving red blood cells and detected by a photodetector. The laser doppler flowmetry 
is determined by the concentration of the red blood cells and the velocity of red blood 
26 
 
cells in a given area. This ultimately represents the blood volume in the given area. 
The output from LDF is expressed in terms of ‘perfusion flux’ instead of simple flow. 
This is because the LDF detects changes in the light that is scattered only by the 
moving red blood cells and not the static cells (20). There are different bands that are 
generated in the laser doppler signal corresponding to the cardiac, respiratory, 
myogenic, neurogenic and endothelial physiological processes. These components 
can be segregated and each of them can be studied individually thereby providing a 
means to assess microvascular changes(20). The disadvantage of LDF is its 
restriction in assessing only one region area of interest.  
All the above conventional methods of assessing blood flow in the lower limbs 
predominantly represent the macrovascular status of the limb with no direct 
measurement of the microvascular blood flow. Therefore, a need arose to explore 
methods which assess the changes in microvascular blood flow of the foot. This led 
to interest in alternate modalities like photoplethysmography. There was also a 
foreseeable need to find methods to assess distal blood flow over the foot accurately. 
Since photoplethysmography is a more direct indicator of the local blood flow in a 
particular area, it can arguably be considered a better representative of the distal blood 
flow in the foot.  
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3.4 PHOTOPLETHYSMOGRAPHY 
Photoplethysmography (PPG) is an optical non-invasive mode of detecting changes 
in the pulsatile arterial blood flow. It is an indicator of volume changes in the 
peripheral arteriovenous channels.  
The word ‘plethysmos’ is derived from Greek and means  ‘increase’.  
The photoplethysmograph waveform consists of a pulsatile AC (Alternating current) 
component and a relatively stable DC (Direct current) component. The pulsatile AC 
component corresponds to the cardiac cycle and has a frequency of usually 1 Hertz. 
This AC component is superimposed on the DC component. The DC component is 
determined by physiological changes in the autonomic nervous system, respiratory 
system and the thermoregulatory system (21). The DC component is also affected by 
the native tissue characteristics and the average circulating blood volume in the area 
of interest. 
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Figure 4. Illustration of the AC component and the DC component. The AC 
component is dynamic whereas the DC component is more dependent on the variable 
native tissue characteristics.  The waveform captured by the PPG is predominantly 
the pulsatile AC component. (22)  
 
3.4.1 PPG WAVEFORM 
A typical PPG waveform has an anacrotic phase followed by a dicrotic phase 
(includes the dicrotic notch). Figure 5 demonstrates an ideal PPG waveform which 
includes a systolic peak and diastolic peak corresponding to the respective phases in 
a normal cardiac cycle (23). In the figure P1 denotes the peak systolic amplitude, P2 
denotes the peak diastolic amplitude and t1 denotes the time period between two 
peaks. The systolic peak is directly influenced by the blood volume ejected during 
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systole of the cardiac cycle. The diastolic peak on the other hand is influenced by the 
systemic vascular resistance.  
 
Figure 5. Ideal PPG waveform with systolic and diastolic peaks 
PPG is being studied as a good indicator of heart rate variability (HRV) and changes 
in blood volume. Heart rate variability is assessed by studying the systolic peaks in a 
typical PPG waveform. 
Another parameter that can be measured is the pulse transit time(PTT) i.e., the time 
taken for the pulse wave to travel from the aorta to the peripheral region of interest. 
The pulse transit time has an inverse relationship with the blood pressure (24). This 
PTT has been used for non-invasive continuous measurement of blood pressure.   
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Another variable that has been studied using PPG is the pulse wave velocity (PWV). 
PWV refers to the velocity of the arterial pulse from one arterial segment to another. 
The pulse wave velocity is a determinant of the arterial compliance. When there is 
arterial rigidity or stiffness secondary to multiple factors including diabetes mellitus, 
it is reflected as a change in pulse wave velocity.  
There are studies which have proposed the concept of pulse rate variability (PRV) as 
a surrogate for heart rate variability(HRV). The difference between PRV and HRV is 
the transit time taken for the blood column to travel from the heart to the periphery. 
Hence PRV is dependent on the pulse transit time (PTT).  
In a study by Hsu et al, there was significant correlation between the peak time ratios 
( also known as crest time ratios) and the arteriosclerotic changes in diabetics and 
non-diabetics (25). 
Nitzan et al analysed the PPG waveforms in diabetics and healthy individuals. 
Different characteristics of the PPG waveform were analysed which included the 
baseline, maximum amplitude and the time period (26).  
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Figure 6. The photoplethysmograph waveform consists of the I0which represents 
incident light irradiance, It which represents transmitted light irradiance and Iab which 
represents absorbed light irradiance. BL represents baseline PPG. AM represents 
amplitude and P denotes the time period (26). 
 
The baseline of the PPG waveform is a function of the blood volume in the area. As 
the blood volume in a particular area increases, the light transmitted through the area 
decreases (because the light is absorbed by the circulating blood and hence less light 
is transmitted to the photodetector). Therefore, in an area with increased blood 
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volume, the baseline PPG signal is low as most of the light is absorbed by the blood 
and there is attenuation of the light. This explained why females had a larger baseline 
PPG as compared to males( the blood volume in females is lower than in males over 
a given surface area).  
One of the most commonly studied aspects of the PPG waveform is the amplitude 
which is directly proportional to the increase in systolic blood volume with each 
cardiac cycle. The amplitude changes in response to the local blood flow. The local 
blood flow in the area is affected by both adrenergic and cholinergic nervous systems. 
However, there is an adrenergic predominance in the hands and feet, thereby 
displaying a marked response to vasoconstriction (27). 
3.4.2 PRINCIPLES OF PPG 
The PPG sensor consists of 
• A light source which is usually a red or infrared light emitting diode (LED)  
• A photodetector. 
There are two types of propagation of the infrared light 
1. Transmittance 
2. Reflectance  
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Figure 7. The first illustration shows transmittance type photoplethysmography and 
the second shows reflectance type photoplethysmography (22)  
 
 
Figure 8.  Light traverses the layers of the skin and is reflected by the red blood cells 
in the cutaneous circulation (28)  
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In the transmittance type the light emitting diode and the photodetector are on 
diametrically opposite sides. Hence the light traverses through the intervening skin, 
bone, vessels and other tissues to fall on the photodetector on the opposite side.  
In the reflectance type the light emitting diode and the photodetector are on the same 
side. Hence the light penetrates the skin and reaches the underlying blood vessels 
where it is reflected back proportional to the blood volume and oxygenation in the 
particular area.   
 The different sites where PPG can be measured are the fingers, toes, forehead, wrist 
and ear since these areas have abundant capillary networks.  
 
3.4.3 OPTICS OF PPG 
The interaction of light with biological tissue can be of varying types- absorption, 
reflection, transmission, scattering, refraction and fluorescence. 
• Concept of optical water window 
Almost 70 percent of the human body is made of water. Water absorbs the 
longer ultraviolet and infrared wavelengths in the range 250- 1000nm. The 
shorter wavelengths are absorbed by the melanin chromophores present on the 
epidermal layer. However, there is a narrow range of wavelength (650nm -
1350nm) corresponding to the red and near infra-red spectra that allows them 
to pass through water. This is sometimes referred to as the near infrared (NIR) 
window or optic window. In this window, there is maximum scattering of light 
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which can be received by the PPG photodetector. This is the rationale for using 
red and near infrared wavelength as the light source in PPG. 
 
Figure 9. Absorption spectrum of water (29) 
 
• Isobestic wavelength 
Blood consists of haemoglobin and deoxyhemoglobin which have varied 
absorption spectra. These are represented as molar extinction coefficient. 
Figure 10 shows that oxyhemoglobin has absorption peaks at 420nm and 580nm          
Deoxyhemoglobin has absorption peaks at 410nm and two secondary peaks at 
550nm and 600nm respectively. 
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The points at which both the curves intersect are termed isobestic points and the 
corresponding wavelengths are referred to isobestic wavelengths. This 
corresponds to about 805nm- near infrared range. At these wavelengths the 
absorption of light is largely independent of blood oxygen saturation.  
 
Figure 10. Absorption peaks of oxyhemoglobin and deoxyhemoglobin (30) 
In summation the optics of PPG is based largely on the Lambert- Beer law(31) 
which states that the light transmittance (A) i.e., the ratio of transmitted light Io to 
incident light I through a particular medium is expressed in terms of its wavelength 
dependent molar coefficient of absorption (ε), concentration of the transmitted media 
(c) and the length (l) of the optical path. 
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Therefore, when light passes through an absorbing medium (example – blood), its 
intensity decreases exponentially as the concentration of the medium and the length 
of the optical path increase.  
3.4.4 APPLICATIONS OF PPG 
Photoplethysmography has found a place in the commercial market for its use in the 
following fields 
1. Measurement of oxygen saturation 
2. Measurement of heart rate and study the variability in PPG with each cardiac 
cycle 
3. To study the physiological effects of respiration 
4. Non-invasive indirect measurement of haemoglobin (32) 
5. Measurement of blood pressure 
Some of the novel applications under research are the use of PPG for measurement 
of venous saturation and its use in measurement of different rheological 
characteristics (eg- clot formations, platelet aggregation, fibrin cross-linking and 
shearing forces on the red blood cells) (33,34) . 
3.4.5 FACTORS AFFECTING PPG 
The PPG signal can be affected by various external factors which include 
- Contact between the skin and the PPG sensor 
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- Motion artefacts and movements of the blood vessel wall (32)  
- Ambient light 
- Ambient temperature which affects the local vasomotor autonomic system and 
thereby indirectly affecting the regional blood flow 
- Local tissue and anatomical factors like thickness of tissue, presence of 
callosities 
- Skin pigmentation 
- Baseline blood flow in the area of interest (25) 
- Orientation of the red blood cells in the blood column 
The light emitting diodes use either the red (600-750nm) or the infra red (850-
1000nm) wavelength bandwidth. However there has been a growing interest in 
exploring other wavelengths of the spectrum in the PPG light emitting diodes. In 
a study by Jiyoung Lee et al it was propounded that the green wavelength PPG 
has less motion artifacts compared to the red or the infrared wavelength PPG (35). 
This can be explained by the observation that longer wavelengths (red and 
infrared) have lesser absorption and hence greater penetration whereas the shorter 
green wavelength has higher absorption and lesser penetration. Therefore as the 
depth of penetration decreased the motion artifacts also reduced. 
 
 Hertzman in 1938 elucidated in great detail the application of PPG in measuring the 
blood flow of the skin in different areas of the body. He also studied the factors 
affecting PPG measurement which included local temperature, underlying surface 
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area of contact, depth of the vascular bed from the skin and intensity of illumination 
(36). 
In a study by Chang et al, the different characteristics of the photoplethysmograph 
waveforms were studied and it was concluded that there was significant difference in 
the PPG characteristics in patients with metabolic syndrome and normal subjects(37). 
Hence, it was proposed that the changes in the arterial wall secondary to the 
biochemical and physiological changes can be detected by PPG. PPG can detect 
changes in the arterial system caused by microvascular insult secondary to varied 
causes.  
In a study by Kim et al, the blood volume ratios between the toe and the finger were 
measured using PPG and doppler (9). A significant difference was established in the 
blood volume ratios in diabetics and non-diabetics. There was a higher blood volume 
change in diabetics. This study also elucidated the possible correlation between skin 
temperature and blood volume changes. Diabetics were found to have increased local 
rise in temperature over the skin of the foot. This could be due to dilation of the 
arteriovenous shunts and poor local vasoconstrictive thermoregulatory mechanism. 
This reiterated the understanding that early changes in the foot secondary to diabetic 
neuropathy and microangiopathy can be detected using non-invasive, easy and 
reproducible alternatives like PPG.  
3.5 NON-CONTACT PHOTOPLETHYSMOGRAPHY 
Apart from the conventional contact photoplethysmography using infrared or near 
infrared sensors, there has been a recent surge of interest in exploring the option of 
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non-contact photoplethysmography. In a pilot study by Nundy et al, a smartphone 
was used to capture videos of the face of subjects. These videos were then analysed 
and the colour of the reflected light was used to assess the heart rate and respiratory 
rate of the subject (38),. The hue (colour) generated from different regions of the face 
was plotted as a function of time and then further processed to calculate the required 
heart rate.  
3.6 PURPOSE OF THIS STUDY 
Photoplethysmography has shown promising results in various biological 
applications and has also been studied as a reliable indicator of the local blood flow 
in a given area. Hence, we have attempted to expand its application in studying the 
changes in the blood flow over the plantar aspect of the foot in diabetics who had 
undergone amputation. As these individuals had already lost a part or whole of one 
lower limb, the other limb was indeed precious. This reiterated the imminent need to 
effectively detect changes in the foot of the precious limb as early as possible. We 
hoped to use photoplethysmography as an effective, reliable screening tool in 
diabetics to detect early microvascular changes in the foot. This would further pave 
the way for decreasing the incidence of amputations and promote limb preservation. 
It would enhance the quality of life of the patients affected with diabetes and help in 
timely intervention to preserve the precious limb.  
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4. METHODOLOGY 
4.1 FUNDING AND APPROVAL 
This study was approved by IRB Min No. 10364 dated 03.11.2016 (Annexure 1). 
Funding for the study was given by the Fluid Research Grant (Annexure 2). 
 
4.2 STUDY DESIGN 
It was designed as a prospective case control study.  
 
4.3 SETTING 
The study was conducted in the inpatient wards under the Department of General 
Surgery Units I to IV, Christian Medical College, Vellore. 
The measurement of toe pressures both for cases and controls was done in the 
Vascular Laboratory in the Surgery Outpatient department.  
The development, calibration and technical modifications of the 
photoplethysmograph device was done in the Department of Bioengineering, 
Christian Medical College, Vellore. 
The period of recruitment was from January 2017 to June 2018. 
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4.4 PATIENT POPULATION 
The patients recruited for the study were from the inpatient wards. The predominant 
patient population was from Tamil Nadu, West Bengal, Andhra Pradesh and 
Bangladesh.  
 
4.5 INCLUSION CRITERIA 
Cases 
All patients (age > 18 years) who were known to have type II diabetes mellitus and 
had undergone any form of amputation in one lower limb (includes both major and 
minor amputations i.e., ray amputations, transmetatarsal amputations, below knee 
amputations, above knee amputations) were included. Their diabetic control status 
was assessed by measuring HbA1c levels.  
Controls 
Age- and gender- matched individuals without diabetes mellitus who had not 
undergone any form of amputation were recruited as controls. The age matching 
allowed an interval of two standard deviations i.e., +/- two years of age.  
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4.6 EXCLUSION CRITERIA 
• Patients with traumatic amputation. 
• Patients with known vascular disease requiring surgical intervention 
• Patients with ulcers over the precious foot 
 
4.7 INFORMED CONSENT  
Both cases and controls were explained about the proposed study. They were given 
the information sheet elucidating the details of the study after which they were given 
adequate time to ask questions. The information sheet and consent form were 
available in English, Hindi, Tamil, Telugu and Bengali. The informed consent was 
then obtained from the subject in the presence of a witness.  
 
4.8 DATA COLLECTION 
The data collection was done solely by the principal investigator. All the cases and 
controls were recruited according to the inclusion criteria. Demographic details of the 
subjects were collected which included name, age, gender and address. The diabetic 
status was assessed and the subjects were interviewed regarding the duration of 
diabetes mellitus, treatment details if any and whether they were currently 
experiencing symptoms of diabetes mellitus. Presence of other concomitant illnesses 
including systemic hypertension, chronic kidney disease, peripheral vascular disease, 
ischemic heart disease and cerebrovascular disease were documented.  
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A detailed history of amputation was then elicited with respect to the side of 
amputation, level of amputation and number of amputations.  
Baseline parameters of height, weight, body mass index and blood pressure were 
measured.  
4.8.1 MEASUREMENT OF TOE PRESSURES 
Both cases and controls then underwent measurement of toe pressures in the Vascular 
laboratory in the General Surgery outpatient department. Toe pressures were 
measured as a baseline assessment of the blood flow in both diabetics and non-
diabetics. This is because in current practice toe pressures are considered a reasonably 
fair tool in detecting distal blood flow of the foot.  
The skin surface over the pulp of the hallux was first cleaned with alcohol or an 
alternative antiseptic.  A sensor was then placed over the pulp of the toe and secured 
with a Velcro or adhesive tape.  A digital pressure cuff measuring 2cm in width was 
then securely positioned around the base of the hallux. This cuff was connected to a 
monitor which displayed the normal waveforms corresponding to the cardiac cycle. 
The cuff was then inflated until disappearance of the waveform was noted. The cuff 
was further inflated to about 20mm above this pressure. The cuff was then gradually 
deflated until return of waveform. The cuff pressure at which the first systolic peak 
reappeared was taken as the toe pressure.  
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(A) 
 
(B) 
Figure 11.  Measurement of toe pressures. (A) The sensor around the hallux with the 
cuff surrounding it. (B) Systolic waveform on the screen 
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4.8.2 LABORATORY INVESTIGATIONS 
According to the inclusion criteria, all the cases had type II diabetes mellitus. Their 
diabetic status was assessed by measuring the HbA1c levels.  
All the controls were non diabetic and this was confirmed by assessing for symptoms 
of hyperglycemia and measuring random blood glucose values (according to the 
American Diabetes Association 2018 for diagnosis of type II diabetes mellitus, the 
presence of classic symptoms of hyperglycemia or hyperglycemic crisis with random 
blood glucose levels of ≥ 200mg/dl is one of the criterion for diagnosis of type II 
diabetes mellitus) (39) 
4.8.3 USE OF PHOTOPLETHYSMOGRAPHY TO ASSESS BLOOD FLOW 
The photoplethysmograph sensors consisted of an infrared light emitting diode. This 
light emitting diode used the principle of reflectance photoplethysmography where 
the emitter and the receiver were at the same end.  The wavelength was 520 
nanometres.  
The photoplethysmograph measurements were done under standard conditions. The 
subjects were placed in the supine position, relaxed and acclimatized for 
approximately 5 minutes before the examination. The subjects were not allowed to 
smoke, drink beverages containing caffeine or use medications with vasoactive 
effects atleast two hours before examination. The foot was thoroughly examined for 
the presence of scars, deformities, ulcers, callosities, pigmentation and any other 
visible or palpable abnormality. 
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The plantar aspect of the foot was cleaned with an alcohol based antiseptic solution. 
The Photoplethysmograph sensors were placed on the sole of the foot and each sensor 
covered an area of 3cm2 over the following points  
- hallux 
-medial forefoot 
-middle forefoot 
-lateral forefoot 
-lateral midfoot 
-heel 
The study was done in three different positions of the patient- 
- supine  
- sitting with the feet on the ground 
- standing 
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In each of the above positions, the sensors were placed in the same six anatomical 
positions over the plantar aspect of the foot. The sensors were securely positioned 
using adhesive tape. A contact pressure was ensured in all the stages either using a 
black muslin cloth in the supine position and a sponge as a force cushion under the 
foot to maintain pressure in the sitting and standing positions. The vertically applied 
pressure was precalibrated in the Department of Bioengineering using a healthy 
subject with the help of a weighing machine as a tool to assess force under recording 
foot and monitored by a force guage. This helped in validating the use of these sensors 
for patients of any stature, build, weight and height.  
The sensors were directly connected to an indigenously designed data acquisition 
system called CMCdaq (Christian Medical College data acquisition system). This 
device was designed by the Bioengineering Department of Christian Medical 
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College, Vellore. It consisted of a preamplifier and set of low pass filters.  It also had 
an inbuilt current-to-voltage converter circuit and an analog-to-digital converter card 
operating at a sampling rate of 1000 Hz.  
The data generated from the CMCdaq was routed to a laptop which had the user 
interface software for CMCdaq.  
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Figure 12. The six photoplethysmography sensors with the preamplifier  
 
 
Figure 13. The indigenous CMC data acquisition system with input from all six 
channels and output routed to a laptop  
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Figure 14. Integrated setup showing the sensors from the foot with preamplifiers 
connected to the CMCdaq and further routed to the laptop 
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Figure 15. Schematic representation of the entire setup showing receiver, input, 
processing and output. 
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Figure 16. CMCdaq user interface showing the pre-recording settings for the six 
channels required for recording the waveform 
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Figure 17. Six channels showing the PPG waveform in the respective six 
regions of the foot.  
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The waveforms were represented as time- domain waveforms in arbitrary units. The 
raw data of waveforms was passed through a low-pass filter of 5Hz and the baseline 
drift was also eliminated using a baseline filter. This enabled the data to have minimal 
noise.  
The waveform consisted of an upstroke culminating in the peak amplitude. This 
corresponded to the systolic phase of the cardiac cycle. It was followed by a 
downstroke corresponding to the diastolic phase of the cardiac cycle. The X- axis 
represented the time domain.  
At the end of data collection there were three segments of waveforms generated – one 
for each of the positions assumed by the patient as mentioned above and each 
recording segment was of a duration of one minute.  
Each segment further consisted of six waveform PPG recordings from each of the six 
anatomical landmarks over the foot. Thus, at the end of the recording there were 
eighteen sets of waveforms generated for analysis.  
Each segment that was recorded was processed further by using baseline correction 
and low pass digital filtering to smoothen the data and limit data noise to a minimum. 
This processed data was then exported as a text format as shown in Figure 18. 
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Figure 18. PPG Waveforms exported as text file for further analysis 
These values corresponded to the respective points on the waveform. This data was 
then analysed using a self written program on the MATLAB R2018a (9.4.0.813654) 
version.  
The different characteristics of the waveform that were analysed were  
1. Peak amplitude – First the peaks and troughs were identified as shown in 
Figure 19. The peak amplitude was then calculated as the difference between 
the peak and the trough. Further the mean peak amplitude for a given segment 
of waveform was calculated.  
2. Peak time – this was calculated as the time taken to attain the peak amplitude. 
This was also referred to as the rise time.  
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A graphical superimposed waveform for all the six regions was also generated as 
depicted in figure 20. This allowed visual appreciation of the difference in the 
amplitude in the six regions of the foot.  
This exercise was repeated for all the three segments with six waveforms each. 
 
Figure 19.  The peaks denoted in green and the troughs in red. Peak amplitude 
calculated as the difference between the peak and trough.  
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Figure 20. Superimposed waveforms from all six regions of the foot  
 
4.8.4 CHALLENGES ENCOUNTERED AND MITIGATION MEASURES 
TAKEN 
• One of the earliest difficulties faced involved calibration of the device.  As this 
was an indigenously developed design it required intensive modelling and re-
modelling of circuits which was generously done by the Department of 
Bioengineering on multiple occasions. Each of the photoplethysmograph 
sensors were soldered to the underlying circuit and subsequently wired to the 
CMCdaq.  
• Once the recruitment and recording commenced, there were numerous 
occasions when the sensors malfunctioned.  One of the probable reasons was 
the undue pressure on the sensors when the study was in the sitting or standing 
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positions. This issue was resolved by securing the sensors onto a firmer and 
sturdier base. There were also instances when new sensors had to be procured 
to replace the defunct ones.  
• The CMCdaq, the in-house data acquisition system was one of the most 
efficient and compact data acquisition systems. However, once the recording 
of data began, it was noticed that in order to process large volumes of data 
being received through six sensors over the foot, a few technical aspects of the 
circuitry and the mother board involving the CMCdaq had to be readjusted to 
meet the demands. This was also resolved promptly by our Department of 
Bioengineering.  
• On placing the sensors over different regions of the foot, there was an initial 
incongruity in the waveforms generated. There was immense noise affecting 
the data output. Also, it required that each sensor be placed and adjusted on 
the foot in an attempt to visualise the best waveform. This was done on a trial 
and error basis where the sensors were placed on a particular region of the foot 
and then had to re-sited around the region of interest until the desired 
waveform appeared. This cumbersome task was overcome by introducing low 
pass filters into the system which helped in eliminating majority of the noise 
generated and also ensured greater sensitivity of the sensors.  
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4.8.5 DIAGRAMMATIC ALGORITHM OF THE STUDY                                                                                                                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All patients with type 2 diabetes 
mellitus who had undergone any 
form of lower limb amputation were 
recruited as cases.  
Patients with no diabetes and no 
history of amputation were 
recruited as controls.  
• Informed consent obtained  
• Collection of demographic details 
• Laboratory biochemical 
investigations- HbA1c levels 
measured for diabetics recruited as 
cases and random blood glucose levels 
measured for controls to rule out 
diabetes mellitus 
Patients with traumatic 
amputations, known 
vascular disease requiring 
surgical intervention and 
patients with ulcer over the 
precious foot were excluded 
62 
 
 
 
 
 
 
 
 
 
 
 
                                                                        
 
 
 
 
 
 
 
 
 
 
 Toe pressures were measured in vascular 
laboratory for both cases and controls 
Multipoint contact photoplethysmograph 
sensors were placed on the sole of the 
precious foot in six regions namely the 
hallux, heel, medial forefoot, middle forefoot, 
lateral forefoot and lateral midfoot.  
The photoplethysmograph waveforms 
generated were routed through the CMC data 
acquisition system to a laptop 
Processing and filtering of data was done 
using the CMCdaq user interface 
Data was exported for further analysis and 
interpretation 
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4.9 STATISTICAL METHODS 
CALCULATION OF SAMPLE SIZE 
With reference to Hubena G et al, the range of peak time from the 
photoplethysmography waveform was found to be 140-154 ms among the diabetic 
group and 120-133 ms among the non-diabetic group (40). Assuming 150 ms for 
diabetic group and 130 ms for the non-diabetic group with an expected difference 
between the groups to be 20 ms, with alpha error at 5% and with a maximum power 
of 80% for a two-sided test, we needed to study at least 42 cases and 42 controls. 
Two Means - Hypothesis testing for two means 
Pulse Peak time 
Table 1 
Standard deviation in group I (Pulse 
peak time in milliseconds 
35 ms 
 
Standard deviation in group II (Pulse 
peak time in milliseconds 
30 ms 
 
Mean difference (Expected difference)  20 ms 
Effect size  0.615385 
Alpha error (%)  5 
Power (1- beta)(%) 80 
1 or 2 sided 2 
Required sample size per group  42 
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Based on mean pulse amplitude with proportion of 69%to 86% among the diabetic 
and 37% to 54% among the non-diabetic and assuming the proportion to be 75% and 
50% respectively with the power at 80% and alpha error at 5% for a two-sided test 
we needed to study 58 diabetic amputees and 58 normal subjects. 
Two Proportion - Hypothesis Testing - Large Proportion - Equal Allocation 
Mean Pulse amplitude 
Table 2 
Proportion in group I (Mean amplitude 
among Diabetic group)  
0.75 
 
Proportion in group II (Mean amplitude 
among Non Diabetic group)  
0.5 
 
Estimated risk difference 0.25 
Power (1- beta) %  80 
Alpha error (%) 5 
1 or 2 sided  2 
Required sample size for each arm  58 
 
   n = 
2𝑆𝑝 2[𝑍1−𝛼 2⁄
+𝑍1−𝛽]2
µ2
  
        𝑠𝑝
2 =  
𝑆1
2+𝑆2
2
2
 
Where 𝑆1
2 =Standard deviation in the first group 
       𝑆2
2 = Standard deviation in the second group 
      µ2 = Mean difference between the samples 
      α   = Significance level 
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1-  β = Power 
           N=
{𝑍1−𝛼 2 ⁄
√2 𝑃 ( 1−𝑃) +𝑍1−𝛽  √𝑃1 (1−𝑃1)+ 𝑃2(1−𝑃2}2
(𝑃1− 𝑃2)2
 
P = 𝑃1 + 𝑃2
2
 
 α   = Significance level 
1 – β = Power  
𝑃1  = Proportion in the first group  
𝑃2 =  Proportion in the second group 
Therefore, considering both parameters namely peak amplitude and peak times the 
sample size was calculated as 58 in each arm.  
During the period of recruitment, 58 cases and 58 controls were recruited. However 
for eight out of the 58 cases, the photoplethysmograph waveforms were significantly 
erratic and with inherent data noise. The data generated from these eight cases was 
not feasible for analysis of the peak amplitudes and peak times due to poor quality of 
the waveforms generated.  
Following attempts were made to address the problem- 
• Adjustment of the photoplethysmograph sensors over the foot 
• Ensuring proper connections between the sensors and the data acquisition 
system  
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• Re-soldering and repair of two of the sensors that had abruptly stopped 
recognising signals 
• Repair of two ports in the CMC data acquisition system which were producing 
poor waveform output 
• Attempt to reduce noise and filter data using the CMC data acquisition 
software 
Despite the above rectifications,  the waveform output generated was not suitable for 
analysis. Therefore, out of the 58 cases recruited findings from eight cases had to be 
excluded from the final analysis.  
Thus, there were 50 cases and the corresponding matched 50 controls that were finally 
analysed. The power of the study was re-calculated with 50 cases and 50 and found 
to be between 74% to 86% which was within acceptable limits.  
Data entry was done using EpiData 3.1 and the analysis was done using Statistical 
Package for Social Sciences (SPSS) version 21. 
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5. RESULTS 
A total of 50 cases and corresponding age and gender matched 50 controls were 
analysed.  
GENDER  
Males constituted 72 percent of the cases and controls whereas females constituted 
the remaining 28 percent.  
 
Figure 21. Distribution of males and females in the study (n =100) 
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AGE DISTRIBUTION 
The average age in cases was 54.84 years with a standard deviation of 8.36. Since the 
controls were age and gender matched, the average age in controls was 54.66 with 
standard deviation of 8.90. 
 
Figure 22. Age distribution (n=50) 
 
DURATION OF DIABETES 
The duration of diabetes mellitus in cases was noted. The maximum number of cases 
had a duration of diabetes between 61-120 months i.e., five to ten years. The mean 
duration was 110.96 months with a standard deviation of 76.40. 
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Figure 23. Duration of diabetes mellitus among cases (n=50) 
 
TREATMENT FOR DIABETES 
Of the fifty diagnosed cases of diabetes mellitus, 49 were under treatment for the 
same. 22 of the cases were on oral hypoglycemic agents alone, 22 were on both oral 
hypoglycemic agents and insulin and four patients were on only insulin. Two cases 
were not on any treatment as they were newly diagnosed.  
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Figure 24. Treatment taken for diabetes mellitus among cases 
 
The other data collected included height, weight, body mass index and blood 
pressure. As demonstrated in Table 3, there was no statistically significant difference 
between cases and controls except for diastolic blood pressure. It was noted that the 
diastolic blood pressure in controls was higher than in cases. However, in both cases 
and controls the diastolic blood pressure was within the normal range, hence it would 
be safe to assume that it had low clinical significance.  
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Table 3 
VARIABLES Cases(n=50) 
Mean±SD 
Controls(n=50) 
Mean±SD 
p Value 
Age (in years) 54.84±8.36 54.66±8.9 0.917 
Height (in cm) 166.44±6.70 163.46±10.27 0.093 
Weight (in kg) 66.86±8.81 66.28±15.40 0.818 
Body Mass Index 24.08±2.26 24.26±5.41 0.822 
Systolic Blood pressure (mm 
Hg) 
119.00±12.50 120.08±10.18 0.64 
Diastolic Blood Pressure 
(mm Hg) 
71.48±8.72 75.36±6.57 0.014 
Toe Pressures (mm Hg) 100.48±44.45 96.2±44.24 0.624 
 
The mean height among cases was 166.40cm and among controls was 163.46cm. The 
mean weight among cases was 66.86kg and among controls was 66.28kg. As was 
evident, there was no significant variation between the two groups with respect to the 
height and weight. The mean body mass index was 24.08 among the cases and 24.26 
among the controls which again did not show statistical significance.  
The mean toe pressures in the cases group (100.48 mm Hg) was higher than controls 
(96.2 mm Hg) but there was no statistically significant difference between the two 
groups. 
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COMORBID ILLNESSES 
The associated comorbid illnesses analysed were systemic hypertension, chronic 
kidney disease, ischemic heart disease, peripheral vascular disease and 
cerebrovascular disease.  
 
Figure 25. Comorbid illnesses among cases and controls (n=50 cases + 50 controls) 
 
The most prevalent comorbid illness amongst both cases and controls was systemic 
hypertension. 44% of the cases and 22% of controls had systemic hypertension. On 
application of the Pearson Chi-square test, the p-value was 0.019 showing a 
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statistically significant difference between the two groups.  This reiterates the positive 
association of diabetes mellitus with systemic hypertension.  
LEVEL OF AMPUTATION 
All cases had undergone amputation at different anatomic levels. Ray amputation 
constituted 42% of the amputations, followed by 38% of below-knee amputations. 
Transmetatarsal amputation and above-knee amputation constituted 16% and 4% of 
the cases respectively.  
 
Figure 26. Level of amputation in cases (n=50) 
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HbA1c LEVELS 
The serum HbA1c levels in cases were analysed and majority of the diabetics had 
HbA1c between 8.1-10%. The mean HbA1c level was 9.156 with a standard 
deviation of 2.22.  
 
Figure 27. HbA1c levels among cases (n=50) 
 
PHOTOPLETHYSMOGRAPH WAVEFORMS 
The parameters of the photoplethysmography that were assessed were 
• Peak pulse amplitude  
• Time taken to attain the peak amplitude.  
PEAK AMPLITUDE 
The peak amplitudes were arbitrarily measured in volts. However, the data obtained 
for peak pulse amplitude required logarithmic transformation to normalise the data. 
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After normalisation of data it was subjected to analysis.  The mean and standard 
deviation was calculated for each position. The data was then analysed using 
Levene’s test for equality of variances and independent t-test for equality of means. 
The results were presented after applying antilogarithmic function.  
As shown in Tables 4,5 and 6, in the supine position it was observed that in all the 
six regions of the foot, the peak amplitude in cases was consistently higher than the 
peak amplitude in controls. However, statistically significant difference was seen in 
three regions of the foot namely medial forefoot, middle forefoot and lateral forefoot.   
The other two positions i.e., sitting and standing, did not show significant difference 
in the peak amplitude between the cases and controls in any of the regions of the foot.  
 PEAK TIMES 
The peak time was measured in seconds. The mean and standard deviation was 
calculated using t-test. The data was then analysed using Levene’s test for equality of 
variances and independent t -test for equality of means.  
The peak times were analysed for both cases and controls for all three positions. There 
was statistically significant difference in the peak time in the heel of the foot in the 
sitting position. However, there was no other region with significant difference in the 
peak times between cases and controls.  
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SUPINE 
Table 4 
 
MEASURED 
PARAMETERS 
CASES    
(n=50)  
CONTROLS 
(n=50) 
 
p VALUE 
MEAN 
±SD        
MEAN ± SD 
HALLUX 
  Peak amplitude  
  Peak time 
 
0.37 ± 3.59 
0.22 ± 0.05 
 
0.29 ± 4.44 
0.23 ± 0.03 
 
0.391 
0.462 
MEDIAL FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.11 ± 3.39 
0.22 ± 0.05 
 
0.06 ± 3.25 
0.23 ± 0.03 
 
0.014 
0.472 
MIDDLE FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.10 ± 2.23 
0.23 ± 0.05 
 
0.03 ± 4.30 
0.23 ± 0.02 
 
<0.001 
0.708 
LATERAL 
FOREFOOT 
  Peak amplitude  
  Peak time 
 
 
0.10 ± 2.86 
0.22 ± 0.56 
 
 
0.02 ± 3.86 
0.23 ± 0.03 
 
 
<0.001 
0.133 
LATERAL MIDFOOT 
  Peak amplitude  
  Peak time 
 
0.12 ± 2.32 
0.22 ± 0.05 
 
0.09 ± 3.82 
0.27 ± 0.28 
 
0.372 
0.258 
HEEL 
  Peak amplitude  
  Peak time 
 
0.04 ± 3.46 
0.42 ±1.27 
 
0.03 ± 4.67 
0.23 ± 0.03 
 
0.246 
0.300 
 
Cases: The mean peak amplitude in the supine position was 0.109 volts with standard 
deviation of 3.497 volts. The mean peak time was 0.254 seconds with standard 
deviation of 0.522 seconds. 
Controls: The mean peak amplitude in the supine position was 0.063 volts with 
standard deviation of 3.975 volts. The mean peak time was 0.236 seconds with 
standard deviation of 0.117 seconds.  
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SITTING 
Table 5 
 
MEASURED 
PARAMETERS 
CASES 
(n=50) 
CONTROLS 
(n=50) 
 
p VALUE 
MEAN ± SD    MEAN ± SD 
HALLUX 
  Peak amplitude  
  Peak time 
 
0.19 ± 3.56 
0.22 ± 0.06 
 
0.21 ± 4.35 
0.22 ± 0.03 
 
0.706 
0.486 
MEDIAL FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.07 ± 3.22 
0.23 ± 0.05 
 
0.06 ± 3.63 
0.22 ± 0.02 
 
0.617 
0.164 
MIDDLE FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.05 ± 2.77 
0.24 ± 0.06 
 
0.04 ± 2.97 
0.23 ± 0.03 
 
0.700 
0.424 
LATERAL 
FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.06 ± 3.78 
0.24 ± 0.05 
 
0.05 ± 4.30 
0.23 ± 0.03 
 
0.251 
0.290 
LATERAL MIDFOOT 
  Peak amplitude  
  Peak time 
 
0.08 ± 3.56 
0.23 ± 0.05 
 
0.11 ± 4.14 
0.22 ± 0.03 
 
0.211 
0.153 
HEEL 
  Peak amplitude  
  Peak time 
 
0.02 ± 3.90 
0.24 ± 0.06 
 
0.04 ± 4.31 
0.22 ± 0.02 
 
0.058 
0.024 
 
Cases: The mean peak amplitude in the sitting position was 0.063 volts with standard 
deviation of 3.975 volts. The mean peak time was 0.235 seconds with standard 
deviation of 0.054 seconds.  
Controls: The mean peak amplitude in the sitting position was 0.069 volts with 
standard deviation of 4.223 volts. The mean peak time was 0.224 seconds with 
standard deviation of 0.027 seconds.  
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STANDING 
Table 6 
 
MEASURED 
PARAMETERS 
CASES 
(n=50) 
 CONTROLS 
(n=50) 
 
p VALUE 
MEAN ± SD MEAN ± SD 
HALLUX 
  Peak amplitude  
  Peak time 
 
0.25 ± 4.22 
0.23 ± 0.05 
 
0.26 ± 3.03 0.22 ± 
0.04 
 
0.883 
0.339 
MEDIAL FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.07 ± 4.95 
0.23 ± 0.05 
 
0.06 ± 3.63 
0.23 ± 0.04 
 
0.620 
0.835 
MIDDLE FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.06 ± 4.01 
0.23 ± 0.51 
 
0.06 ± 3.78 
0.23 ± 0.04 
 
0.807 
0.656 
LATERAL FOREFOOT 
  Peak amplitude  
  Peak time 
 
0.05 ± 5.1 
0.23 ± 0.05 
 
0.04 ± 5.05 
0.23 ± 0.04 
 
0.538 
0.839 
LATERAL MIDFOOT 
  Peak amplitude  
  Peak time 
 
0.05 ± 5.31 
0.22 ± 0.04 
 
0.09 ± 4.90 
0.22 ± 0.03 
 
0.096 
0.632 
HEEL 
  Peak amplitude  
  Peak time 
 
0.01 ± 7.17 
0.24 ± 0.05 
 
0.02 ± 7.10 
0.24 ± 0.04 
 
0.488 
0.464 
 
Cases: The mean peak amplitude in the standing position was 0.057 volts with 
standard deviation of 6.165 volts. The mean peak time was 0.230 seconds with 
standard deviation of 0.049 seconds. 
Controls: The mean peak amplitude in the standing position was 0.063 volts with 
standard deviation of 5.395 volts. The mean peak time was 0.226 seconds with 
standard deviation of 0.036 seconds.  
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BOX PLOTS SHOWING RELATIONSHIP BETWEEN THE THREE 
POSITIONS AND PEAK AMPLITUDE IN CASES AND CONTROLS 
 
1. 
 
Figure 28. A box plot showing the peak amplitude for both cases and controls in all 
the six regions of the foot.  
It is observed that the maximum amplitude in both cases and controls is at the hallux.  
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2. 
 
Figure 29. Box plot showing the peak amplitude in the three different positions 
 
On further analysing each region of the foot in the three different positions, it was 
found that in all three positions, the maximum amplitude was consistently high at the 
hallux. 
 
 
 
81 
 
 
RECEIVER OPERATING CHARACTERISTIC CURVES 
1. 
 
Figure 29.  ROC plotted for the peak amplitudes in three different positions namely 
supine, sitting and standing. 
The ROC plotted showed significant area under the curve (AUC) and p-value only 
for the supine position.  
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Table 7 
POSITION AUC p- VALUE 
SUPINE 0.592 <0.01 
SITTING 0.479 0.383 
STANDING 0.500 0.986 
 
 
2. 
 
Figure 30.  ROC plotted for the peak amplitudes in the supine position for all the six 
regions of the foot namely hallux, medial forefoot, middle forefoot, lateral forefoot, 
lateral midfoot and heel.  
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Table 8 
REGION AUC p- VALUE 
HALLUX 0.528 0.627 
MEDIAL 
FOREFOOT 
0.622 0.036 
MIDDLE 
FOREFOOT 
0.677 0.002 
LATERAL 
FOREFOOT 
0.763 <0.001 
LATERAL 
MIDFOOT 
0.513 0.825 
HEEL 0.552 0.374 
 
Since the peak amplitude in supine position showed statistical significance, it was 
further analysed by each region of the foot. Interestingly, the data revealed that all 
three regions of the forefoot namely medial forefoot, middle forefoot and lateral 
forefoot had significant area under the curve and p-value. This translates to better 
discriminative capacity of the PPG sensors to assess blood flow in the forefoot region 
than in the hallux, midfoot or heel. Hence the likelihood of PPG accurately assessing 
the microvascular blood flow in the region of the forefoot is significantly greater than 
the other regions.   
Generalised linear regression models were used to compare the change or difference 
in peak amplitude between the six regions of the foot. As shown in Table 9, hallux 
was taken as the reference region and the other five regions were compared to it. It 
showed statistically significant decrease in the pulse peak amplitude between hallux 
and all the other regions of the foot  
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Table 9 
MEASURED 
PARAMETERS 
(REGION) 
BETA 
VALUE 
 95% 
CONFIDENCE 
INTERVAL 
p VALUE 
Hallux vs Medial 
Forefoot 
-0.465 -0.621, -0.309 <0.001 
Hallux vs Middle 
Forefoot 
-0.521 -0.682, -0.360 <0.001 
Hallux vs Lateral 
Forefoot 
-0.449 -0.688, -0.210 <0.001 
Hallux vs Lateral 
Midfoot 
-0.453 -0.619, -0.286 <0.001 
Hallux vs Heel -0.532 -0.696, -0.367 <0.001 
 
Similarly, the generalised linear model was also used to compare the change in peak 
amplitude between the three positions as shown in Table 10. The supine position was 
taken as the reference and was then compared to sitting and standing positions. It was 
observed that there was statistically significant decrease in the peak amplitude when 
the subject assumed a sitting position from supine position.  
When the position of the subject was changed from supine to standing, there was a 
decrease in the peak amplitude, but it was not statistically significant.  
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Table 10 
MEASURED 
PARAMETERS 
(POSITION) 
BETA 
VALUE 
 95% 
CONFIDENCE 
INTERVAL 
p VALUE 
Supine Vs Sitting -0.230 -0.373, -0.087 0.002 
Supine Vs Standing -0.107 -0.356, 0.142 0.401 
 
TOE PRESSURES 
Pearson correlation statistical analysis was done to assess the relationship between 
peak amplitude and toe pressures. As depicted in table 11, there was significant 
positive correlation between peak amplitude and toe pressures for both cases and 
controls. Even though this positive correlation was not consistent in all six positions 
across the three assumed positions, the overall positive correlation between the two 
different variables is definite.  
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Table 11 
 
VARIABLE 
(Peak 
amplitude) 
SUPINE SITTING STANDING 
Pearson 
correlation 
coefficient 
p- 
Value 
Pearson 
correlation 
coefficient 
p- 
Value 
Pearson 
correlation 
coefficient 
p- 
Value 
HALLUX 
Cases 
 
Controls 
 
0.298 
 
0.425 
 
0.036 
 
0.002 
 
0.379 
 
0.225 
 
0.007 
 
0.117 
 
-0.058 
 
0.118 
 
0.688 
 
0.415 
MEDIAL 
FOREFOOT 
Cases 
 
Controls 
 
 
0.026 
 
0.313 
 
 
0.860 
 
0.027 
 
 
0.243 
 
0.184 
 
 
0.089 
 
0.200 
 
 
0.156 
 
-0.019 
 
 
0.279 
 
0.898 
MIDDLE 
FOREFOOT 
Cases 
 
Controls 
 
 
0.114 
 
0.415 
 
 
0.429 
 
0.003 
 
 
0.169 
 
0.380 
 
 
0.242 
 
0.006 
 
 
0.104 
 
0.174 
 
 
0.473 
 
0.226 
LATERAL 
FOREFOOT 
Cases 
 
Controls 
 
 
-0.001 
 
0.145 
 
 
0.992 
 
0.314 
 
 
0.120 
 
0.266 
 
 
0.405 
 
0.062 
 
 
0.163 
 
0.410 
 
 
0.258 
 
0.003 
LATERAL 
MIDFOOT 
Cases 
 
Controls 
 
 
0.079 
 
0.145 
 
 
0.585 
 
0.317 
 
 
0.044 
 
0.415 
 
 
0.761 
 
0.003 
 
 
0.054 
 
0.388 
 
 
0.711 
 
0.005 
HEEL 
Cases 
 
Controls 
 
0.167 
 
0.460 
 
0.245 
 
0.001 
 
-0.227 
 
-0.035 
 
0.113 
 
0.807 
 
-0.068 
 
-0.052 
 
0.640 
 
0.721 
 
 
 
87 
 
 
DURATION OF DIABETES 
The relation between peak amplitude and duration of diabetes mellitus was analysed 
as shown in Table 12. Interestingly, there was significant negative correlation 
between the peak amplitude in the supine position in the hallux and medial forefoot 
with duration of diabetes. 
However, in the sitting position there was significant positive correlation between the 
peak amplitude in middle forefoot and lateral midfoot with duration of diabetes.  
There was also positive correlation between peak amplitude in lateral midfoot in 
supine position and duration of diabetes.  
In the standing position there was no correlation between the peak amplitude and 
duration of diabetes in any of the regions of the foot.  
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Table 12 
 
VARIABLE 
SUPINE SITTING STANDING 
Pearson 
correlation 
coefficient 
p- 
Value 
Pearson 
correlation 
coefficient 
p- 
Value 
Pearson 
correlation 
coefficient 
p- 
Value 
HALLUX 
Peak     
amplitude 
 
-0.351 
 
 
 
0.012 
 
 
 
-0.123 
 
0.393 
 
-0.243 
 
0.089 
MEDIAL 
FOREFOOT 
Peak 
amplitude  
 
 
 
-0.298 
 
 
0.035 
 
 
-0.004 
 
 
0.980 
 
 
0.021 
 
 
0.884 
 
MIDDLE 
FOREFOOT 
Peak 
amplitude 
 
 
-0.125 
 
 
 
 
0.386 
 
 
0.307 
 
 
0.030 
 
 
 
0.100 
 
 
 
0.491 
 
LATERAL 
FOREFOOT 
Peak 
amplitude  
 
 
0.307 
 
 
0.03 
 
 
0.041 
 
 
 
 
0.776 
 
 
0.044 
 
 
0.764 
LATERAL 
MIDFOOT 
Peak 
amplitude  
 
 
 
-0.132 
 
 
0.360 
 
 
 
0.330 
 
 
 
0.019 
 
 
0.119 
 
 
 
0.411 
HEEL 
Peak 
amplitude  
 
 
-0.231 
 
0.107 
 
 
0.008 
 
 
0.954 
 
0.117 
 
0.417 
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6. DISCUSSION 
A total of 50 cases and appropriately age and gender matched 50 controls were 
analysed. In addition to demographic details, various physiological parameters 
including height, weight, body mass index and blood pressure were analysed.  
There was no significant variation between the two groups with respect to the height, 
weight and the body mass index. The mean systolic blood pressure was almost 
comparable between cases and controls. However, interestingly the mean diastolic 
blood pressure among controls was significantly higher than in cases but the values 
were within normal limits. 
The aforementioned physiological parameters which included height, weight, body 
mass index and blood pressure could be regarded as potential confounding factors in 
the assessment of peripheral blood flow over the foot. As there was no statistical 
significance amongst cases and controls, it translated to good matching and a 
decreased likelihood of these being confounding variables in the study. Therefore, 
the changes in blood flow as assessed by PPG was more likely only due to the 
variables of interest namely, diabetic status and the presence of amputation of the 
contralateral limb in cases.  
Toe pressures which are widely used as an indirect measure of the peripheral blood 
flow over the foot were measured for both cases and controls and analysed. The mean 
toe pressures measured for the cases were higher than in the control group. This 
corroborates with our understanding that in diabetics, there is an increased stiffness 
of the arteries and arterioles due to extracellular matrix deposition and sclerosis in the 
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tunica media which could explain the higher toe pressures among the cases(40). 
However, there was no statistically significant difference between the cases and 
controls. Therefore, it can be suggested that probably toe pressures alone are not 
sensitive enough to detect early microvascular changes in the contralateral foot in 
patients who had undergone amputation. Even if the precious contralateral foot in our 
cases had early microvascular changes, it was not detected by the conventional toe 
pressures. This further strengthens our purpose of the study to find an alternative 
method to detect early changes.  
A study by Sonter et al comparing the intra-rater and inter-rater reliability of toe 
pressures in diabetics and non-diabetics also showed no statistically significant 
difference in the toe pressures between cases and controls even though toe pressures 
had better reliability when compared to toe brachial index and ankle brachial 
index(41). In a meta-analysis by Sonter Ja it was concluded that low toe pressures ( 
less than 30mm Hg) were associated with poor wound healing and higher risk of 
amputation, however there was a significant heterogeneity in the toe pressures 
measured(42). Therefore, it may be argued that even though absolute values of toe 
pressures are indirect indicators of blood flow of the foot, they may not be the best 
tool to differentiate between the microvascular blood flow in diabetics and non-
diabetics.  
Among the co-existent illnesses analysed it was found that systemic hypertension had 
a higher prevalence among cases which corroborates with the consensus that patients 
with diabetes mellitus have a higher risk of concomitant systemic hypertension. This 
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has been attributed to probably similar mechanism of microvascular injury at the 
molecular level in both diabetes and hypertension (43).  
On analysis of the photoplethysmograph data, the peak amplitude was maximum at 
the hallux for both cases and controls in all three positions consistently. Therefore, 
this indicates that the blood flow in the superficial plantar surface of the hallux is 
more compared to the other pressure points. This confirms the conjecture that in 
diabetics when there is loss of sympathetic tone, opening up of arteriovenous 
channels occur and cause an apparent increase in the blood flow (9). According to the 
results of this study hallux can be considered an important region of the foot for 
assessing microvascular changes that can be easily identified using PPG. Therefore, 
assessment of distal microcirculation is a better indicator of the overall status of the 
foot.   
It was also observed that there was significant difference in the peak amplitude in the 
forefoot region in the supine position between the study and control groups. There 
was an increase in the peak amplitude among cases in all three regions of the forefoot 
namely medial forefoot, middle forefoot and lateral forefoot. This is an important 
result of the study because it has shed light on our understanding of pressure points 
of the foot and the resultant effect of early microvascular changes. Based on the study 
it can be suggested that the forefoot is probably more sensitive and reliable in 
manifesting early microvascular changes. Moreover, there are no previous studies or 
literature which have measured peak amplitudes of PPG in these regions in diabetics 
versus normal subjects.   
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This was further supported by statistical analysis which showed that compared to the 
hallux, the other regions showed a significant decrease in amplitude. Therefore, even 
though hallux is the region of maximum blood flow, the forefoot would be a better 
region to detect change in blood flow in diabetics and non-diabetics.  
This difference was not observed in the other positions namely sitting and standing. 
The common underlying variable is the force exerted in assuming these two positions. 
It can thus be concluded that in the resting supine position with the foot being 
unloaded, the PPG has maximum sensitivity in detecting changes in blood flow 
between diabetics and non-diabetics in the forefoot compared to other regions of the 
foot.  
Another important result of the study was the significant change noticed in the peak 
amplitude when subject assumed a sitting position from supine position. In the sitting 
position, the foot is on the ground with due pressure. Hence, in amputees whose 
precious limb bears a significant load, it has been demonstrated that there is 
significant reduction in the peak amplitude on assuming a sitting position. This can 
be attributed to the cumulative result of direct pressure causing dampening of 
waveforms and early microvascular changes in the foot causing an apparent decrease 
in the amplitude.  
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Important practical implications of the study 
The study has proved with reasonable confidence that photoplethysmography is a 
safe, reliable, non-invasive and sensitive indicator of microvascular changes in the 
foot in diabetics. It has detected changes in the blood flow of the foot even in the 
absence of any external manifestations in the foot.  
In our study PPG has detected changes in blood flow in the two groups which the 
conventional toe pressures failed to detect. This is of considerable significance and 
has far reaching implications in detecting and diagnosing early subclinical changes 
in persons with diabetes even in the absence of ulceration or other gross changes in 
the foot. Hence it may find an important place as a predictor tool for screening 
patients with diabetes. It would serve as an adjunct to the already existing diabetic 
foot clinics in detecting early changes.  
In view of the results of the study we can suggest footwear that would effectively 
address the pressure points in the foot. This would greatly reduce the incidence of 
diabetic foot and subsequent need for amputations.  
In an era where the rates of amputations secondary to diabetes mellitus are increasing 
exponentially, any attempt at limb salvage is a welcome relief.  
Our study has shown promising results towards this objective.  
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7. LIMITATIONS 
At the outset this study was a novel attempt to explore the application of PPG in 
assessing blood flow in the foot. There is very limited literature and background 
knowledge on the use of PPG for this purpose. Therefore, there was lack of adequate 
standardisation and validation of the device used. It required modifications and 
alterations at every step in tandem with new challenges faced during the study. 
However, towards the end of the study it was a robust, indigenous model which 
required further application and use in the future for studying a larger population.  
The PPG waveform is impregnated with countless parameters and variables which 
we are yet to explore. For example, there are various aspects of the waveform 
including area under the curve, pulse width, peak to peak interval, first order 
derivatives, second order derivatives, Fourier transformation and augmentation 
index, all of which have not been studied. This study has generated data that needs 
further intense analysis, comprehension and interpretation.   
According to the results of the study, the effect of pressure over the PPG sensors in 
the sitting and standing positions was quite significant thereby causing occasional 
dampening of the waveforms. Design modifications maybe needed in future to 
address this issue.  
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8. CONCLUSION 
In congruence with our primary objective the peak amplitude and peak times were 
established in the contralateral limb in diabetic patients who had undergone 
amputation. There was significant increase in the peak amplitude among the 
amputees with diabetes as compared to non - diabetics. The mean peak amplitudes 
for cases in the supine, sitting and standing positions were 0.109, 0.063 and 0.057 (in 
arbitrary units of volts) respectively. The corresponding mean peak amplitudes in 
controls in supine, sitting and standing positions were 0.057, 0.069 and 0.063 (in 
arbitrary units of volts) respectively.  
The mean peak time for cases in the supine, sitting and standing positions were 0.254 
seconds, 0.235 seconds and 0.230 seconds respectively. The corresponding mean 
peak time for controls in the supine, sitting and standing positions were 0.236 
seconds, 0.224 seconds and 0.226 seconds respectively. However, there was no 
statistically significant difference. 
Hence peak amplitude was a better indicator of the changes in blood flow than peak 
times.  
In fulfilment of secondary objectives, the different regions of the foot were mapped 
according to their blood flow and it was established that the hallux had maximum 
blood flow but the forefoot was a better representative of the change in blood flow.   
This study can therefore be considered a basis for adopting the use of PPG to assess 
distal microvascular blood flow as it is more representative of the local blood flow 
when compared to other conventional modalities.  
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We can also recommend the use of appropriate footwear for the precious limb in 
diabetic amputees with due consideration to the forefoot region.  
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ANNEXURE 2  
“ Role of multipoint contact photoplethysmography in assessing changes in 
blood flow in the plantar aspect of the contralateral foot following amputation 
in patients with type 2 diabetes mellitus” 
DATA EXTRACTION/CLINICAL RESEARCH FORM 
DATA EXTRACTION SHEET 
IRB Protocol ID: 
Hospital ID                  
Unique ID number     
Demographic details 
Name: 
Age:             
Gender: Male       Female 
Address: 
Phone number:          
History 
1)Known patient of diabetes mellitus               Yes          No               
•  If yes, duration of diabetes                      
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                                                                           YY               MM 
2)Whether on medical treatment for diabetes              Yes         No 
• If yes, what is the treatment?                Oral hypoglycemic agents only 
                                                                     Insulin only 
                                                                     Both oral hypoglycemic 
agents                 
                                                                          and insulin 
                                                                     Irregular treatment      
 
3) Whether currently experiencing any of the following symptoms 
                                                                                Increased thirst 
                                                                                Increased hunger 
                                                                                Increased urination              
4)Comorbid illnesses 
• Systemic hypertension                               Yes          No  
• Chronic kidney disease                               Yes          No 
• Peripheral vascular disease                       Yes          No  
• Ischemic heart disease                               Yes          No  
• Cerebrovascular disease                            Yes          No 
5)Medication history – Name and dose of          
drugs being taken                                                   ____________      ____________ 
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6)History of amputation of the lower limb                                 Yes         No                          
(includes toe amputation, foot amputation,                                                          below 
knee amputation and above knee amputation)  
 
• If yes, what was the level of amputation (check all the boxes that apply 
and provide the date of surgery) 
Clinical parameters 
1) Height (in cm)                                    
Tick 
the 
boxes 
Side  Anatomical site  Date of surgery 
 Right  First toe  
 Right  Second toe   
 Right  Third toe  
 Right  Fourth toe  
 Right  Fifth toe  
 Right  Transmetatarsal  
(amputation at the level of midfoot) 
 
 
 Right  Below knee  
 Right  Above knee  
 Left First toe  
 Left Second toe  
 Left Third toe  
 Left Fourth toe  
 Left Fifth toe  
 Left  Transmetatarsal  
(amputation at the level of midfoot) 
 
 
 Left  Below knee  
 Left  Above knee  
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2) Weight (in kg) 
                      
3) Body mass index                 
 
4) Blood pressure (mm Hg)             
  
5) Toe pressures measurement over the big toe of the precious foot (mm 
Hg) 
 
Side Toe pressures (mm Hg) 
  
 
 
Laboratory investigations 
1) HbA1c (in percent) – To be done for all patients                  
with diabetes who have undergone amputation 
                                                                                          
2) Random blood glucose levels(mg/dl) – To be                                                      
done for all individuals planned to be taken in the                     
comparison group, in order to rule out diabetes 
3) Photoplethysmography data 
Which foot is being studied?                  Right             Left  
 
Supine 
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Anatomical region Peak amplitude(millivolts) Peak times(milliseconds) 
Hallux   
Heel   
Medial forefoot   
Middle forefoot   
Lateral forefoot   
Lateral midfoot    
 
Sitting 
Anatomical region Peak amplitude(millivolts) Peak times(milliseconds) 
Hallux   
Heel   
Medial forefoot   
Middle forefoot   
Lateral forefoot   
Lateral midfoot    
 
 
 
 
Standing 
Anatomical region Peak amplitude(millivolts) Peak times(milliseconds) 
Hallux   
Heel   
Medial forefoot   
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Middle forefoot   
Lateral forefoot   
Lateral midfoot    
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ANNEXURE 3 – CONSENT FORM  
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ANNEXURE 4 – INFORMATION SHEET 
TITLE OF STUDY 
Role of multipoint contact photoplethysmography in assessing changes in blood flow in the plantar 
aspect of the contralateral foot following amputation in patients with type 2 diabetes mellitus. 
PATIENT INFORMATION SHEET 
 
You are being asked to enroll in a study that aims to measure changes in blood flow over the foot 
using the technology of “photoplethysmography”. Please take time to read/listen to the following 
information. The study personnel will be available to answer any questions/clarifications that you 
may have in this regard. 
 
Description of the study 
The study aims to use the technology of “photoplethysmography” which is a simple, non-invasive 
device that uses light waves to measure changes in blood flow over a particular area of the body. 
This will be used in the form of small sensors placed over the sole of the foot which will measure 
the blood flow and display the information on a computer. The sensors will be placed in the following 
locations- the big toe, heel and four other points over the sole of the foot. The entire process will 
take only about ten minutes. You will also undergo measurement of your toe pressures. Measurement 
of toe pressures is a painless, non-invasive investigation which involves placement of a sensor and 
a small blood pressure cuff on the big toe for about two minutes.  A photograph of the foot will also 
be taken using a smart phone.  
For diabetics who have undergone amputation and are to be enrolled in the study, a blood test called 
HbA1c will be done which indicates the blood sugar control over the past three months. 
For normal individuals who will form part of the control group, a random blood sugar level will be 
checked and if found to be less than 200mg/dl in the absence of symptoms of increased thirst, 
increased appetite and increased urination, then they will be included in the study as the control 
population. 
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Advantages or expected benefits of being enrolled in the study 
There are no immediate benefits to being a part of this study. There will be no change in the treatment 
provided. There are no monetary benefits provided. The results of this study will be useful for future 
patients in identifying areas of the foot that show early harmful changes due to diabetes. 
 
Foreseeable risks or inconveniences  
You might experience some discomfort or pain while blood is withdrawn for checking blood glucose 
levels and HbA1c levels. You will not be asked to pay for any of the tests or procedures during the 
course of the study. 
 
Study participation and withdrawal 
Refusal to participate in the study or withdrawal from the study will not lead to any penalty, 
compromise of your medical care or loss of benefits. 
 
Confidentiality of the data collected 
The data collected shall remain strictly confidential. Only the study personnel will be able to match 
your identity to the collected data. If the results of the study are published, you will not be named in 
any of the publication or presentation of results. 
 
In addition to the information provided above, if you have any further questions or clarifications, 
kindly contact principal investigator.  
 
 
 
 
115 
 
ANNEXURE 5- DATA SET 
slno cc idno hospno name age gender address phno 
1 1 2 567039G V.SUDHAKAR 42 1 EGUVACHENTHAPALLI,TIRUPATHI,517561 9652709440 
2 2 1 830337G DR.G.P.REDDY 41 1 3/547,ARAVINDA NAGAR,KADAPPA,AP. 9703413302 
3 1 4 726364 PAUL PADMANABHAN 45 1 NAINIAPPAN STREET,KAGITHAPATTARAI,VELLORE. 9566541304 
4 2 3 594669G ARUMUGAM S 43 1 21/15,METTU ST,SORAKALPET,KATPADI VELLORE 9585450928 
5 1 6 589153G ASOKAN 46 1 462,KOIL ST,CHINNA KOMESWARAM,AMBUR,VELLORE. 9843590841 
6 2 5 168549H VIJAYARANGAN 46 1 3,MUNISAMY ST,TOWN ARCOT VELLORE. 8524860501 
7 1 8 936314G BALAJI 50 1 4/3,ARUNDATHI MEL ST,SAMARIKSHI KUPPAM,GUDIYATTAM, 9629747924 
8 2 7 450545B RAMU 48 1 5,5TH CROSS ST,BHARATHI NAGAR EXTN.THARAPADAVEDU. 9952388602 
9 1 10 359510B ANANDARAJ 50 1 100,SRINIVASA NAGAR BYPASS ROAD,VELLORE. 9952126099 
10 2 9 236154H M.S VISVANATHAN 48 1 SEELANAIKENPATTI,5/258 ALAGUNAGAR,SALEM,TN,636201. 9003762629 
11 1 12 935194G ELUMALAI 58 1 SAIDAPET,VELLORE 8675672678 
12 2 11 388789D SWAPAN DAS 58 1 TUFANGANJ,LANGALGRAM,COOCH BEHA,WB. 9474431380 
13 1 14 990277G DILIPKUMAR GHOSH 52 1 POOGABAGAN,BHAGABANDH,BANKURA,WB,722146 9593817199 
14 2 13 221369H JEBASELVAN 54 1 4/20,5TH CROSS ST. SAMAYAPURAM,PORUR,CHENNAI. 9841795512 
15 1 16 815356F MD.PHIROJKHAN 46 1 102,RAJABAN,P.O.P.S,RANIGANJ,BARDHWAN,WB. 7319392964 
16 2 15 915760B RAJA 46 1 1/4,EB NAGAR,PHASE 3,SATHUVACHARI,VELLORE 
 
17 1 18 046215H GAUTAM NAG 53 1 KATIGORAH,LACHAR,ASSAM 9954159630 
18 2 17 306321F SHAHNUR 52 1 9,SOUTH CENTRAL RD,KHULNA,BANGLADESH 9748409045 
19 1 20 482692G SRINIVASAN 55 1 144,PILLAIYAR KOIL ST.PONAMPET,WALLAJAH. 9843245461 
20 2 19 307640H SUDHARSHAN 57 1 413/A GANDHI MAIN ROAD,SADUPERI,VELLORE 9786939408 
21 1 22 975732G CHANDAN MAITI 63 1 20/32,BAGMUNDI,PURULIA,WB. 9332179255 
22 2 21 546949F SESHAGIRI RAO B. 64 1 12-21-24/3,ST.ANNS HOSTEL GATE,NARASARAO PETGUNTUR 8333947371 
23 1 24 938501G ARUMUGAM 56 1 155/A VANNIYAR ST,RAGHUNADHAPURAM,VIL,T.V.MALAI 9865599849 
24 2 23 365898G SOLAPURI 58 1 214,MURUGAR KOIL ST,FILTER BED MEDU ,OT,VELLORE 8190864559 
25 1 26 829623D SEKAR G 56 1 44/23,NATTARAMPALLI,TIRUPATTUR. 9944020697 
26 2 25 197627H PRABIR KUMAR 58 1 SAYAM APT,FLAT F-2 36,BIDHAN PARK BARGANAS WB. 8335080346 
27 1 28 304157h sagadevan k. 55 1 43,MALAPPA MANDIR ST,THUTHIPET,ADUKAMPARAI,VELLORE 8870360474 
28 2 27 108346H REGI 57 1 KERETH GARDEN,KUMULI,IDUKKI,KERALA. 9447065719 
29 1 30 576632A NIRANJAN DAS 57 1 HARAKUMAR,KANTAL BERIA WB,741126 8348648849 
30 2 29 579925G MANI 58 1 GOVINDASAMY,KONNERIKUPPAM ST,KONNERI,VELLORE 9597445726 
31 1 32 144799H MD.TAHIR MIRZA 57 1 11,HARUN BARI 1ST LANE,CHITTARANJAN AVENUE KOLKATT 8420957389 
32 2 31 363154F SEKAR P. 58 1 60,KALIKAPURAM,EDAYANSANTHU,VELLORE 9952390433 
33 1 34 685656C MAHESHWARAN 55 1 4/115,PILLAIYAR KOIL ST,VANDRANTHANGAL,VELLORE. 9843348488 
34 2 33 241751H MD.SHAMSUL HAQ FAKIR 57 1 WEST MOHD BAGH-962,MERAJ NAGAR,BANGLADESH 9007060219 
35 1 36 383613D THAMBIDURAI 58 1 31,ANNA ST,KALINJUR,KATPADI,VELLORE. 9894940542 
36 2 35 664666G ABDUL RAHMAN 60 1 CHARAK PATHAR,KALYANPUR,DHANBAD,JHARKAND.826004 7654676005 
37 1 38 406713D PARIMAL SARKAR 59 1 LANKAMURA POST OFFICE,TRIPURA AGARTALA 8794057407 
38 2 37 235802H FEKADU 61 1 ADDIS ABABA,HOUSE-148,ETHIOPIA 6385583185 
39 1 40 585387G VEERAMANI 61 1 162,DR.AMBEDKAR NAGAR,BANGALORE ROAD,VELLORE FORT. 9994516055 
40 2 39 305449H MANIKAM 60 1 1/120 mallgunda,vaniyambadi,vellore. 9688142738 
41 1 42 149525H CHITTARANJAN 63 1 PO,BANKADAHA,BANKURA,WB. 7908696484 
42 2 41 163889H NARASIMHA 62 1 H.NO.15-56,SREERAMULU ST,MADANAPALLI,CHITOOR,AP. 9177117354 
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43 1 44 996296G DEVDASS C 65 1 VENKATASAMUDRAM,VELLORE 9597618644 
44 2 43 195137H SADASIVAM 63 1 PARIYA KOLAPADI,CHENGAM,TIRUVANNAMALAI.600704 9943368567 
45 1 46 589577G VIJAYAKUMAR 65 1 53,DHANALAXMI NAGAR,PUDHUR PUDUMANAI,GUDIYATTAM, 9080593120 
46 2 45 228889H BIRENDRA 63 1 MAUJA FATEHPUR,J.L.NO.131,MURSHIDABAD,WB,742132 9264591587 
47 1 48 939454G VELLIYAN 65 1 KOVAMPATTU VILLAGE,13/NA,T.V.MALAI,632102 9159482368 
48 2 47 161147H M.P.VERMA 63 1 SOUTH BANKATI,336 B,GOPALGANJ,BIHAR,841409 8235048835 
49 1 50 948878F P.VIJAYAKUMAR 52 1 ALAMARAM ST,SEDUVALAI,VIRINCHIPUKAM,VELLORE. 9500219703 
50 2 49 934275G THANGAVEL 50 1 PAZHAIYURMARVADI,DHARMAPURI 9942079925 
51 1 52 591321G MAHADEVAN 67 1 1/34,THERKU ST, PULIYANTCON,WALAJAPET. 9487333329 
52 2 51 597472G SUBASH CHANDRAN 66 1 SEETHARAMAN ST,THIPPASAMUDRAM,ANAICUT VELLORE. 782596688 
53 1 54 583380G NATARAJAN 70 1 307/A MANTHOPPU,2ND ST,KAMALAKSHIPURAM,OTTERI,VELL 9629540520 
54 2 53 828438F SYED GOLAM 72 1 SYED MANSION,SOUTH BHATIARY,BANGLADESH 7397604639 
55 1 2 835184G BHAGYALAKSHMI 34 2 2-41,MR PALKI VILLAGE. 9989093455 
56 2 55 385635G SANGEETHA 32 2 32/A,RAMCHETTY ST,VENGALAPURAM,TIRUPATTUR,VELLORE. 992538534 
57 1 58 008453H ROPASHY 42 2 CHOTTAGRAM,NAG COLONY,CHITTAGONG,BANDAR. 9378196119 
58 2 57 995368G BHARTI BISWAS 41 2 HANSKHALI ROAD,BETALA PARA,NADIA,WB,74121. 8158800578 
59 1 60 937257G SARASWATHI R. 45 2 A3/14,NORTH POLICE QUARTERS,BANGALORE ROAD,VELLORE 8015638954 
60 2 59 096389G RINKU SAHA 45 2 DUM DUM,GHUGU DANGA,24,PARGANAS,KOLKATA 9836477714 
61 1 62 937771G RANI 45 2 1ST STREET,VASANTHA NAGAR,KONAVATTAM. 9360215795 
62 2 61 091453H PUSHPA PRADHAN 44 2 ECHEY BUSTY,KALIMPONG,DARJEELING 9933025518 
63 1 64 591883G SANTANAHORE 48 2 ASHOKNAGAR NORTH,24,PARGANAS,WB. 9232575618 
64 2 63 388780D ANIMA DAS 46 2 TUFFANGAN,LANGALRAM,COOCH BEHAR WB. 9474431380 
65 1 66 183025H POONGOTHU 53 2 161,VELAPADI ST,KARUNKALIKUPPAM,PUTHUR POST. 7094182494 
66 2 65 112255H REENA BORAH 54 2 KALIMPONG,10,MICE TUNY BOTAY,DARJEELING. 9732774085 
67 1 68 926686G MST LAILY BEGUM 49 2 110,CHOTOBONGRAM,POLLOBI ABASIK SOPURA,RAJASTHAN 
 
68 2 67 041928F SAROJ 50 2 8,KEDAR DUTTA LANE BANKURA KOLKATTA 8489037909 
69 1 70 594697G YASHODAMA 60 2 18-1-519,BAVANI NAGAR,TIRUPATI. 9493430197 
70 2 69 351186H CHANDRABAI R. 60 2 KARLAMPAKKAM VILLAGE,THIRUVALLUR 6380533095 
71 1 72 936455G MUTHULAKSHMI 60 2 14/12,GANDHIJI ST.THORAPADI,VELLORE. 9566708751 
72 2 71 351266H RUKAMMAL 62 2 230,MADHAVELI,WALAJAH,TN. 9566347272 
73 1 74 596819G BHAGBATI 69 2 MAMUDPUR,TEGHORI JOTEVIRAM PURBA ,MEDIPUR,WB. 6281921548 
74 2 73 802802B MENAKA 67 2 41,PHASE1,TNHB,SATHUVACHARI,VELLORE. 7708078560 
75 1 76 350862H LILA GORE 53 2 BENAGARIA,BANKURA,WB. 6296939941 
76 2 75 051049H PRATIMA MAITRA 53 2 IOC ROAD,WARD 35,SAHID COLONY,BAKTHI NAGAR,WB. 9564955695 
77 1 78 591541G NAWAB T A 66 1 DALAL GARDEN,REDITHOPE,AMBUR. 8248778704 
78 2 77 930614G SATHYAM CHETTY 64 1 QR.NO.LIG 37Q,BAKUI ROAD,JAMSHEDPUR. 8092148123 
79 1 80 826790G SUCHANDRA GUHA 44 2 MAHAJATI NAGAR,AGARPARA NORTH24,PARGANAS,WB. 8981586387 
80 2 79 212787H AMENA KHATUN 42 2 HOUSE3 MOULOVIPARA,1ST LANE KHULNA,BANGLADESH 
 
81 1 82 669299C PREMA 58 2 36,SANJEEVIPURAM,BAGAYAM,VELLORE. 9092495006 
82 2 81 874186C RAMIZA BEE 60 2 46,3RD STREET,KUMARAPPA NAGAR,KATPADI. 9080978098 
83 1 84 327109J VENKATESAN 53 1 PILLAIAR KOIL ST,YADAMARI VILLAGE CHITOOR. 9025548481 
84 2 83 303980H YOGENDRA SINGH 52 1 SONAS VILLAGE,KHIZERSARAI,GAYA NADARA,GAYA,BIHAR/ 9939716513 
85 1 86 784063D VENKATESAN K P 64 1 34,NEW STREET,VELLORE. 999426784311 
86 2 85 596240G SUBRAMANI 63 1 261,NAVITHAR STREET,VELIAGRAM,PALLIPATU,THIRUVALLU 9751335869 
87 1 88 934108G VILVANATHAN 73 1 SANDIMATU ST,MALPATI,VELLORE. 9047497771 
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88 2 87 306242H SASADHAR 75 1 SIJUMAKHANA VILLAGE,DAPAH PO PURULIA,WB. 9382068305 
89 1 90 961657G MAMUD MULLA 51 1 MAHESDARI SOUTH 24 PARGANAS WB. 8420890267 
90 2 89 180313H POULRAJ 49 1 25-559-73,OLD PRASANTH NAGAR,CHITOOR,AP. 9701720711 
91 1 92 932817F CICILIN 55 2 4/128,WIKRAMASI MEDU,VADUGANTHANGAL,VELLORE. 9055740428 
92 2 91 145041G SUSAMA CHAUDARI 54 2 BANKURA PRATAP BAGAN,BANKURA,WB. 9474019331 
93 1 94 475493F CHINNA PANCHULIYA 57 1 2-1975/4,CHENNA REDDY ST,PILER,CHITOOR. 9959388429 
94 2 93 594229G MUNIYAPPAN 60 1 22,KURINJI NAGAR,SATHUVACHARI 9843690585 
95 1 96 187188H KUPPURAJ G 43 1 215,JJ NAGAR,KUPPAMPATTI ROAD,JALAGANDAPURAM. 9750602908 
96 2 95 938865G MANIKANDAN 42 1 37,RAMAR KUDUYIRUPPU,KALAMBUR THIRUVANNAMALAI. 9677571910 
97 1 98 271287H HRIDYANAND 47 1 GHWATI,KAMRUP,ASSAM 9952288062 
98 2 97 377360F VIJAYAKUMAR 45 1 LADAMA SIDHAPA,MADHUBANI,BIHAR 9674162116 
99 1 100 591851G RAHMAN S 52 1 20-166,RANGA REDDY STREET,CHITOOR. 9133356665 
100 2 99 661046D SARAVANAN 50 1 1A,3RD WEST CROSS ROAD,GANDHINAGAR,VELLORE. 9994086366 
         
 
slno 
  1 dm dmyes dmtreat dmtreatyes symptom htn ckd pvd ihd cvd 
2 1 3 1 3 4 0 0 0 0 0 
3 0  0  4 0 0 0 0 0 
4 1 120 1 1 4 1 0 0 1 0 
5 0  0  4 0 0 0 0 0 
6 1 12 1 1 4 0 0 0 0 0 
7 0  0  4 0 0 0 0 0 
8 1 1 1 1 4 0 0 0 0 0 
9 0  0  4 0 0 0 0 0 
10 1 180 1 1 4 0 0 0 0 0 
11 0  0  4 0 0 0 0 0 
12 1 120 1 1 4 1 0 0 1 0 
13 0  0  4 0 0 0 0 0 
14 1 84 1 3 4 1 0 0 0 0 
15 0  0  4 0 0 0 0 0 
16 1 48 1 1 4 0 0 0 0 0 
17 0  0  4 0 0 0 0 0 
18 1 184 1 3 4 1 0 0 0 0 
19 0  0  4 0 0 0 0 0 
20 1 156 1 3 4 1 0 0 0 0 
21 0  0  4 0 0 0 0 0 
22 1 96 1 3 4 1 0 0 0 0 
23 0  0  4 0 0 0 0 0 
24 1 120 1 3 4 1 0 0 0 0 
25 0  0  4 0 0 0 0 0 
26 1 36 1 3 4 0 0 0 0 0 
27 0  0  4 0 0 0 0 0 
28 1 60 1 1 4 0 0 0 0 0 
29 0  0  4 1 0 0 0 0 
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30 1 60 1 1 4 0 0 0 0 0 
31 0  0  4 0 0 0 0 0 
32 1 180 1 2 4 0 0 0 0 0 
33 0  0  4 1 0 0 0 0 
34 1 120 1 3 4 1 0 0 0 0 
35 0  0  4 1 0 0 0 0 
36 1 72 1 3 4 1 0 0 0 0 
37 0  0  4 0 0 0 0 0 
38 1 360 1 3 4 1 0 0 0 0 
39 0  0  4 0 0 0 0 0 
40 1 108 1 3 4 0 0 0 0 0 
41 0  0  4 0 0 0 0 0 
42 1 72 1 1 4 0 1 0 0 0 
43 0  0  4 1 0 0 0 0 
44 1 84 1 1 4 1 0 0 0 0 
45 0  0  4 0 0 0 0 0 
46 1 60 1 3 4 0 0 0 0 0 
47 0  0  4 0 0 0 0 0 
48 1 36 1 1 4 0 0 0 0 0 
49 0  0  4 1 0 0 0 0 
50 1 120 1 1 4 1 0 0 0 0 
51 0  0  4 0 0 0 0 0 
52 1 144 1 1 4 0 0 0 0 0 
53 0  0  4 0 0 0 0 0 
54 1 180 1 1 4 0 0 0 0 0 
55 0  0  4 0 0 0 0 0 
56 1 6 1 3 4 0 0 0 0 0 
57 0  0  4 0 0 0 0 0 
58 1 12 1 3 4 1 0 0 0 0 
59 0  0  4 0 0 0 0 0 
60 1 60 1 2 4 0 0 0 0 0 
61 0  0  4 0 0 0 0 0 
62 1 2 0  4 0 0 0 0 0 
63 0  0  4 0 0 0 0 0 
64 1 240 1 1 4 0 0 0 0 0 
65 0  0  4 0 0 0 0 0 
66 1 84 1 1 4 0 0 0 0 0 
67 0  0  4 1 0 0 0 0 
68 1 276 1 3 4 1 0 0 0 1 
69 0  0  4 1 0 0 0 0 
70 1 96 1 3 4 1 0 0 0 0 
71 0  0  4 0 0 0 0 0 
72 1 180 1 3 4 1 0 0 0 0 
73 0  0  4 0 0 0 0 0 
74 1 48 1 4 4 0 0 0 0 0 
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75 0  0  4 0 1 0 0 0 
76 1 60 1 2 4 0 0 0 0 0 
77 0  0  4 1 0 0 0 0 
78 1 180 1 1 4 0 0 0 0 0 
79 0  0  4 1 0 0 0 0 
80 1 60 1 2 4 1 0 0 0 0 
81 0  0  4 0 0 0 0 0 
82 1 240 1 3 4 1 0 0 0 0 
83 0  0  4 1 0 0 0 0 
84 1 84 1 1 4 1 0 0 0 0 
85 0  0  4 1 0 0 0 0 
86 1 180 1 3 4 1 0 0 0 0 
87 0  0  4 0 0 0 0 0 
88 1 108 1 1 4 0 0 0 0 0 
89 0  0  4 0 0 0 0 0 
90 1 60 1 1 4 0 0 0 0 0 
91 0  0  4 0 0 0 0 0 
92 1 120 1 1 4 0 1 0 0 0 
93 0  0  4 0 0 0 1 0 
94 1 180 1 1 4 0 0 0 1 0 
95 0  0  4 0 0 0 0 0 
96 1 120 1 3 4 1 0 0 0 0 
97 0  0  4 0 0 0 0 0 
98 1 216 1 3 4 1 0 0 0 0 
99 0  0  4 0 0 0 0 0 
100 1 120 1 3 4 0 0 0 0 0 
 0  0  4 0 0 0 0 0 
 
 
 
          
 
slno height weight bmi sysbp diasbp side toepress hbalc Rbgl           
1 170 62 21.45 110 70 2 60 6.4  
2 189 100 27.99 120 80 2 176  120 
3 165 70 25.71 130 50 2 80 11.6  
4 168 55 19.49 130 70 2 0  111 
5 167 72 25.82 110 70 2 50 7.1  
6 154 75 31.62 130 70 2 110  124 
7 166 68 24.68 130 60 2 154 6.6  
8 158 74 14.1 120 80 2 50  90 
9 178 70 22.09 140 80 2 60 12.9  
10 168 70 24.8 140 80 2 166  109 
11 172 69 23.32 110 70 2 80 11.6  
12 171 70 23.94 110 80 2 80  114 
13 169 60 21.01 130 80 2 140 11.1  
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14 166 70 25.4 110 70 2 110  181 
15 172 74 25.01 140 80 1 160 11.7  
16 169 65 22.76 120 80 1 120  87 
17 164 62 23.05 120 70 1 140 7  
18 170 76 26.3 130 90 1 180  122 
19 171 85 29.07 110 70 1 70 8  
20 163 53 19.95 138 82 1 120  128 
21 169 70 24.51 110 70 2 160 10.7  
22 164 82 30.49 120 80 2 90  119 
23 169 70 24.51 110 70 2 80 9.9  
24 166 68 24.68 110 80 2 20  129 
25 169 72 25.21 110 70 2 60 7  
26 171 69 23.6 110 80 2 150  122 
27 170 71 24.57 120 70 2 60 6.5  
28 174 96 31.71 140 85 2 170  82 
29 171 72 24.62 110 70 2 20 9.2  
30 155 56 23.31 120 70 2 30  105 
31 172 86 29.07 110 70 1 70 8.3  
32 170 85 29.41 136 86 1 130  98 
33 173 90 30.07 120 70 1 90 8.1  
34 167 68 24.38 120 70 1 90  113 
35 171 70 23.94 110 70 2 140 8.7  
36 165 60 22.04 130 80 2 150  111 
37 172 64 21.63 120 64 2 80 10.7  
38 170 68 23.53 110 70 2 50  116 
39 172 69 23.32 110 70 1 110 8.5  
40 152 43 18.61 110 60 1 90  114 
41 172 69 23.32 110 70 1 40 8.1  
42 185 90 26.3 120 85 1 120  92 
43 172 69 23.32 110 60 2 70 7.4  
44 169 70 24.51 120 70 2 100  112 
45 171 70 23.94 110 80 1 50 10.5  
46 168 69 24.45 120 70 1 70  115 
47 170 71 24.57 110 70 1 120 4  
48 165 68 24.98 140 80 1 80  173 
49 171 70 23.94 130 80 2 70 11.1  
50 165 68 24.98 110 80 2 80  121 
51 163 76 28.6 120 70 2 60 8.9  
52 162 60 22.86 120 70 2 70  142 
53 163 60 22.58 110 70 2 130 13  
54 160 69 26.95 130 70 2 40  112 
55 159 61 24.13 110 70 2 150 11.6  
56 170 76 26.3 110 60 2 80  85 
57 161 62 23.92 110 70 1 200 7.4  
58 169 69 24.16 110 80 1 120  100 
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59 160 62 24.22 80 40 1 90 8  
60 149 101 45.49 110 70 1 90  134 
61 159 61 24.13 120 70 2 160 7.6  
62 148 68 31.04 110 70 2 100  87 
63 163 69 25.97 110 60 2 60 12.1  
64 161 66 25.46 110 70 2 60  110 
65 161 45 17.36 110 70 1 140 9.3  
66 142 48 23.8 120 80 1 110  96 
67 162 63 24.01 150 80 1 100 7.3  
68 148 50 22.83 120 80 1 130  116 
69 159 61 24.13 130 80 2 90 11.9  
70 152 54 23.37 110 70 2 40  121 
71 150 50 22.22 140 90 1 80 8.1  
72 151 45 19.74 110 70 1 80  132 
73 150 48 21.33 110 60 1 120 6.5  
74 150 44 19.56 130 80 1 120  92 
75 151 52 22.81 120 60 1 200 9.2  
76 135 37 14.07 140 70 1 90  98 
77 170 72 24.91 130 80 1 70 10.9  
78 170 64 22.15 130 70 1 130  116 
79 171 73 24.96 130 80 1 210 6.7  
80 172 71 24 110 70 1 100  129 
81 159 58 22.94 130 80 1 110 9.3  
82 157 80 32.46 130 70 1 90  126 
83 176 68 21.95 120 80 1 100 9.2  
84 173 61 20.38 120 80 1 80  110 
85 164 75 27.89 130 80 2 70 13.5  
86 163 49 18.44 110 70 2 60  102 
87 169 68 23.81 110 70 2 40 6  
88 168 50 17.72 110 80 2 90  121 
89 171 68 23.26 110 70 1 120 6.6  
90 172 69 23.32 120 80 1 60  121 
91 153 52 22.21 130 80 2 130 8.9  
92 148 47 21.46 130 80 2 44  129 
93 169 60 21.01 130 80 1 90 10.2  
94 168 61 21.61 110 70 1 140  122 
95 172 68 22.99 140 80 1 140 14  
96 162 37 14.1 110 70 1 50  102 
97 157 61 24.75 130 80 1 80 9  
98 170 100 34.6 110 80 1 80  160 
99 170 75 25.95 110 70 2 70 9.9  
100 171 70 23.94 120 80 2 220  123 
 
 
slno 
1 whichfoot halluxpa halluxsda halluxpt halluxsdt medialpa medialsda medialpt medialsdt  
122 
 
2 2 1.43 0.092 0.234 0.01 0.546 0.075 0.246 0.027  
3 2 0.684 0.042 0.206 0.002 0.13 0.007 0.209 0.033  
4 2 0.981 0.071 0.205 0.003 0.373 0.055 0.205 0.007  
5 2 0.209 0.014 0.237 0.016 0.034 0.003 0.253 0.44  
6 2 0.002 3.643 0.226 0.079 0.091 0.003 0.216 0.006  
7 2 1.338 0.044 0.233 0.017 0.122 0.013 0.225 0.057  
8 2 0.929 0.025 0.211 0.003 0.344 0.008 0.199 0.003  
9 2 0.657 0.036 0.192 0.008 0.067 0.003 0.187 0.021  
10 2 0.282 0.003 0.222 0.005 0.014 0 0.253 0.072  
11 2 0.073 0.044 0.217 0.003 0.065 0.009 0.22 0.032  
12 2 1.722 0.049 0.225 0.002 0.677 0.033 0.234 0.002  
13 2 1.713 0.124 0.226 0.008 0.198 0.028 0.205 0.024  
14 2 0.517 0.016 0.241 0.003 0.568 0.017 0.241 0.003  
15 2 0.012 0.001 0.236 0.047 0.014 0.002 0.227 0.042  
16 1 0.902 0.024 0.195 0.001 0.081 0.005 0.199 0.008  
17 1 0.121 0.026 0.234 0.033 0.059 0.004 0.225 0.005  
18 1 1.078 0.025 0.18 0.003 0.107 0.007 0.196 0.02  
19 1 1.355 0.051 0.2 0.005 0.035 0.004 0.196 0.075  
20 1 0.593 0.047 0.183 0.003 0.317 0.03 0.204 0.004  
21 1 0.406 0.017 0.216 0.004 0.163 0.017 0.218 0.005  
22 2 0.633 0.097 0.286 0.02 0.195 0.039 0.303 0.02  
23 2 0.707 0.203 0.21 0.001 0.075 0.003 0.221 0.004  
24 2 0.044 0.011 0.172 0.033 0.049 0.007 0.164 0.01  
25 2 0.326 0.011 0.198 0.003 0.041 0.002 0.194 0.011  
26 2 0.23 0.012 0.208 0.011 0.267 0.015 0.209 0.006  
27 2 0.074 0.021 0.216 0.016 0.023 0.007 0.236 0.018  
28 2 1.212 0.031 0.212 0.002 0.15 0.003 0.22 0.005  
29 2 0.139 0.003 0.264 0.093 0.138 0.003 0.181 0.039  
30 2 0.34 0.017 0.246 0.005 0.129 0.014 0.249 0.009  
31 2 0.404 0.045 0.257 0.008 0.097 0.007 0.241 0.011  
32 1 0.296 0.015 0.243 0.01 0.014 0 0.192 0.073  
33 1 0.502 0.025 0.186 0.005 0.213 0.009 0.186 0.006  
34 1 0 0 0.257 0.077 0.334 0.016 0.265 0.006  
35 1 0.48 0.043 0.258 0.006 0.093 0.012 0.268 0.014  
36 2 0.217 0.013 0.191 0.012 0.131 0.01 0.192 0.014  
37 2 0.58 0.01 0.242 0.039 0.058 0.003 0.249 0.046  
38 2 0.058 0.011 0.28 0.058 0.136 0.017 0.3 0.008  
39 2 0.094 0.014 0.243 0.01 0.027 0.008 0.264 0.038  
40 1 0.65 0.036 0.195 0.003 0.179 0.013 0.189 0.004  
41 1 0.044 0.005 0.266 0.023 0.008 0.001 0.272 0.025  
42 1 0.606 0.021 0.211 0.004 0.015 0 0.248 0.098  
43 1 0.145 0.002 0.206 0.027 0.086 0.006 0.209 0.004  
44 2 0.408 0.009 0.248 0.004 0.035 0.006 0.234 0.004  
45 2 1.644 0.222 0.255 0.032 0.162 0.037 0.273 0.04  
46 1 0.231 0.012 0.198 0.008 0.043 0.004 0.211 0.007  
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47 1 0.012 0.007 0.181 0.077 0.001 0.001 0.173 0.069  
48 1 0.233 0.02 0.237 0.005 0.119 0.013 0.25 0.007  
49 1 0.132 0.015 0.251 0.062 0.048 0.017 0.214 0.022  
50 2 1.515 0.049 0.221 0.004 0.405 0.024 0.216 0.006  
51 2 0.001 0 0.18 0.115 0.025 0.009 0.198 0.091  
52 2 0.581 0.01 0.21 0.005 0.121 0.006 0.202 0.005  
53 2 0.281 0.008 0.276 0.038 0.014 0 0.264 0.064  
54 2 0.456 0.018 0.217 0.003 0.145 0.006 0.217 0.004  
55 2 0.234 0.025 0.219 0.005 0.026 0.003 0.209 0.013  
56 2 1.979 0.112 0.208 0.006 0.611 0.227 0.26 0.08  
57 2 0.103 0.018 0.221 0.009 0.017 0.005 0.242 0.043  
58 1 0.7 0.028 0.391 0.004 0.159 0.034 0.383 0.006  
59 1 0.543 0.007 0.174 0.006 0.191 0.005 0.207 0.003  
60 1 0.172 0.006 0.275 0.014 0.096 0.003 0.287 0.05  
61 1 0.276 0.009 0.217 0.015 0 0 0.278 0.079  
62 2 0.968 0.021 0.203 0.002 0.218 0.004 0.206 0.002  
63 2 0.131 0.02 0.207 0.049 0.107 0.008 0.187 0.009  
64 2 0.239 0.019 0.209 0.004 0.066 0.007 0.198 0.012  
65 2 0.571 0.101 0.212 0.004 0.062 0.016 0.23 0.056  
66 1 0.014 0.001 0.23 0.018 0.059 0.002 0.247 0.011  
67 1 1.366 0.033 0.214 0.017 0.141 0.005 0.242 0.088  
68 1 0 0 0.3 0.069 0 3.035 0.143 0.073  
69 1 1.742 0.059 0.232 0.005 0.122 0.001 0.251 0.028  
70 2 0.197 0.004 0.195 0.003 0.135 0.002 0.203 0.003  
71 2 0.997 0.047 0.225 0.003 0.145 0.002 0.225 0.006  
72 1 1.221 0.012 0.192 0.002 0.161 0.003 0.196 0.003  
73 1 0.262 0.013 0.197 0.003 0.022 0.002 0.202 0.019  
74 1 0.287 0.011 0.233 0.034 0.014 0.001 0.231 0.026  
75 1 0.143 0.004 0.265 0.047 0.094 0.011 0.254 0.014  
76 1 1.181 0.033 0.207 0.001 0.148 0.001 0.222 0.004  
77 1 0.231 0.063 0.214 0.011 0.146 0.002 0.254 0.094  
78 1 0.074 0.008 0.235 0.131 0.017 0.002 0.237 0.035  
79 1 0.135 0.006 0.2 0.01 0.009 0.001 0.206 0.006  
80 1 1.536 0.056 0.215 0.003 0.161 0.013 0.212 0.014  
81 1 0.633 0.043 0.227 0.01 0.006 0.001 0.222 0.017  
82 1 0.298 0.002 0.262 0.025 0.015 0.002 0.254 0.027  
83 1 1.339 0.037 0.232 0.008 0.247 0.024 0.231 0.006  
84 1 0.178 0.068 0.223 0.007 0.236 0.402 0.223 0.01  
85 1 0.973 0.048 0.335 0.106 0.064 0.011 0.237 0.077  
86 2 0.28 0.005 0.248 0.004 0.014 0 0.268 0.057  
87 2 0.357 0.037 0.25 0.006 0.024 0.003 0.262 0.038  
88 2 0.448 0.194 0.22 0.06 0.876 0.408 0.191 0.018  
89 2 0.07 0.022 0.25 0.062 0.034 0.003 0.338 0.01  
90 1 1.315 0.03 0.212 0.008 1.074 0.028 0.214 0.007  
91 1 0.621 0.019 0.198 0.007 0.116 0.024 0.208 0.025  
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92 2 0.272 0.003 0.22 0.003 0.014 0 0.222 0.006  
93 2 0.553 0.039 0.189 0.076 0.311 0.03 0.195 0.009  
94 1 0.386 0.118 0.204 0.018 0.031 0.012 0.206 0.024  
95 1 1.373 0.083 0.223 0.004 0.389 0.017 0.224 0.005  
96 1 0.132 0.002 0.241 0.004 0.049 0.003 0.243 0.012  
97 1 0.227 0.047 0.253 0.052 0.034 0.003 0.255 0.045  
98 1 0 0.137 0.011 0.228 0 0.065 0.007 0.224  
99 1 0.137 0.001 0.261 0.017 0.135 0.004 0.259 0.012  
100 2 0.461 0.017 0.226 0.003 0.065 0.004 0.229 0.009  
 2 7.458 2.192 0.311 0.093 0.367 0.007 0.209 0.027  
 
slno 
1 middlept middlesdt laterffpa laterffsda laterffpt laterffsdt latermfpa latermfsda latermfpt  heelpa 
2 0.257 0.067 0.144 0.027 0.217 0.024 0.258 0.066 0.256  0.123 
3 0.206 0.047 0.011 0.002 0.258 0.066 0.434 0.03 0.227  0.063 
4 0.208 0.032 0.138 0.012 0.208 0.006 0.242 0.076 0.21  0.121 
5 0.253 0.076 0.023 0.001 0.19 0.075 0.008 0.002 0.271  0.002 
6 0.213 0.016 0.055 0.001 0.216 0.009 0.039 0.002 0.216  0.053 
7 0.198 0.051 0 7.237 0.21 0.089 0 4.929 0.222  0.033 
8 0.203 0.007 0.06 0.002 0.202 0.009 0.208 0.006 0.198  0.732 
9 0.239 0.085 0.036 0.003 0.209 0.519 0.3 0.042 0.195  0.04 
10 0.217 0.062 0.088 0.006 0.21 0.01 0.059 0.003 0.221  0.127 
11 0.264 0.074 0.027 0.013 0.236 0.035 0.305 0.061 0.237  0.636 
12 0.232 0.005 0.335 0.012 0.23 0.003 0.208 0.031 0.236  0.218 
13 0.203 0.055 0.012 0.002 0.213 0.06 0.741 0.052 0.212  0.009 
14 0.242 0.004 0.109 0.004 0.245 0.006 0.165 0.003 0.231  0.042 
15 0.238 0.055 0.003 0.001 0.244 0.059 0.037 0.006 0.23  0.054 
16 0.193 0.014 0.101 0.005 0.197 0.006 0.048 0.004 0.191  0.07 
17 0.229 0.01 0.037 0.003 0.235 0.007 0.145 0.031 0.234  0.067 
18 0.195 0.015 0.046 0.005 0.195 0.023 0.208 0.011 0.179  0.001 
19 0.2 0.021 0.008 0.001 0.203 0.02 0.068 0.015 0.196  0.349 
20 0.196 0.009 0.192 0.016 0.191 0.01 0.493 0.038 0.187  0.073 
21 0.228 0.086 0.028 0 0.197 0.027 0.171 0.011 0.222  0.006 
22 0.297 0.036 0.079 0.012 0.3 0.025 0.102 0.02 0.3  0.242 
23 0.205 0.13 0.005 0.001 0.232 0.03 0.133 0.009 0.215  0.084 
24 0.214 0.047 0.082 0.004 0.163 0.007 0.018 0.008 0.217  0.008 
25 0.228 0.066 0.005 0.001 0.198 0.014 0.016 0.003 0.193  0.016 
26 0.219 0.006 0.224 0.015 0.209 0.007 0.116 0.016 0.212  0.019 
27 0.243 0.054 0.08 0.019 0.238 0.048 0.079 0.038 0.248  0 
28 0.224 0.048 0.058 0.001 0.239 0.067 0.066 0.003 0.232  0.08 
29 0.226 0.008 0.091 0.005 0.233 0.006 0.394 0.013 0.229  0.23 
30 0.244 0.017 0.03 0.003 0.261 0.049 0.055 0.007 0.253  0.05 
31 0.227 0.007 0.078 0.003 0.227 0.007 0.084 0.006 0.227  0.027 
32 0.276 0.049 0.038 0.01 0.257 0.056 0.037 0.012 0.261  0.004 
33 0.227 0.051 0.178 0.013 0.227 0.056 0.209 0.024 0.191  0.102 
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34 0.173 0.091 0 4.834 0.207 0.096 0.185 0.018 0.27  0.269 
35 0.259 0.052 0.041 0.004 0.269 0.037 0.101 0.011 0.268  0.056 
36 0.231 0.069 0.039 0.004 0.187 0.026 0.076 0.056 0.188  0.024 
37 0.226 0.018 0.129 0.01 0.234 0.024 0.5 0.029 0.217  0.027 
38 0.292 0.01 0.131 0.004 0.258 0.014 0.089 0.015 0.295  0.12 
39 0.247 0.068 0.014 0.034 0.283 0.064 0.121 0.034 0.257  0.029 
40 0.192 0.004 0.107 0.006 0.192 0.004 0.218 0.008 0.191  0.074 
41 0.226 0.1 0.001 0 0.302 0.075 0.005 0.001 0.28  0.002 
42 0.202 0.009 0.135 0.011 0.221 0.018 0.253 0.017 0.213  0.013 
43 0.224 0.03 0.028 0.004 0.199 0.018 0.275 0.024 0.211  0.216 
44 0.215 0.007 0.08 0.002 0.223 0.023 0.106 0.007 0.237  0.074 
45 0.281 0.073 0.021 0.004 0.278 0.067 0.029 0.006 0.309  0.031 
46 0.205 0.008 0.161 0.01 0.197 0.003 0.135 0.012 0.201  0.017 
47 0.216 0.038 0.029 0.001 0.153 0.064 0.018 0.005 0.214  0.001 
48 0.237 0.019 0.051 0.004 0.228 0.021 0.091 0.009 0.239  0.064 
49 0.236 0.043 0.024 0.006 0.245 0.048 0.071 0.014 0.239  0.001 
50 0.23 0.072 0 0 0 0 0.133 0.039 0.269  0.125 
51 0.214 0.088 0.007 0.002 0.279 0.129 0.006 0.002 0.167  0.005 
52 0.197 0.01 0.063 0.006 0.2 0.008 0.047 0.007 0.192  0.152 
53 0.238 0.005 0.1 0.003 0.241 0.009 0.269 0.02 0.266  0.007 
54 0.224 0.006 0.155 0.011 0.223 0.005 0.142 0.01 0.228  0.027 
55 0.254 0.077 0.002 0.001 0.211 0.039 0.214 0.021 0.209  0.097 
56 0.315 0.08 0.328 0.051 0.218 0.035 0.588 0.138 0.244  0.177 
57 0.228 0.019 0.026 0.005 0.221 0.014 0.161 0.018 0.225  0.025 
58 0.39 0.004 0.029 0.003 0.394 0.006 0.334 0.037 0.383  0.052 
59 0.202 0.011 0.224 0.005 0.197 0.004 0.244 0.006 0.217  0.038 
60 0.287 0.026 0.057 0.003 0.278 0.019 0.047 0.004 0.272  0.044 
61 0.226 0.03 0.013 0.002 0.218 0.028 0.052 0.007 0.23  0.004 
62 0.21 0.004 0.183 0.004 0.212 0.004 0.056 0.005 0.204  0.026 
63 0.188 0.024 0.031 0.008 0.205 0.044 0.126 0.037 0.194  0.058 
64 0.198 0.023 0.077 0.009 0.196 0.013 0.332 0.015 0.201  0.039 
65 0.221 0.06 0.025 0.006 0.226 0.058 0.053 0.02 0.211   
66 0.252 0.023 0.059 0.004 0.245 0.01 0.057 0.008 0.262   
67 0.163 0.012 0.055 0.003 0.234 0.063 0.127 0.01 0.241   
68 0.26 0.081 8.299 3.27 0.229 0.105 0 1.669 0.136   
69 0.239 0.026 0.005 0 0.256 0.035 0.293 0.049 0.241   
70 0.225 0.009 0.124 0.002 0.199 0.003 0.118 0.004 0.199   
71 0.224 0.041 0.058 0 0.208 0.026 0.291 0.011 2.201   
72 0.197 0.005 0.138 0.002 0.202 0.002 0.289 0.002 0.215   
73 0.219 0.069 0.003 0.001 0.245 0.084 0.015 0.003 0.219   
74 0.211 0.007 0.144 0.008 0.266 0.081 0.28 0.008 0.222   
75 0.238 0.016 0.091 0.009 0.255 0.01 0.335 0.044 0.246   
76 0.216 0.007 0.054 0.002 0.218 0.004 0.061 0.003 0.216   
77 0.225 0.005 0.058 0 0.233 0.107 0.146 0.003 0.214   
78 0.234 0.044 0.008 0.001 0.233 0.087 0.034 0.005 0.233   
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79 0.196 0.016 0.049 0.005 0.202 0.016 0.126 0.005 0.2   
80 0.21 0.024 0.117 0.011 0.206 0.014 0.124 0.019 0.21   
81 0.215 0.03 0.014 0.001 0.223 0.016 0.174 0.023 0.225   
82 0.202 0.004 0.149 0.001 0.257 0.021 0.285 0.011 0.229   
83 0.23 0.041 0.016 0.002 0.23 0.012 0.205 0.03 0.243   
84 0.214 0.329 0.056 0.012 0.205 0.006 0.088 0.011 0.232   
85 0.225 0.06 0.031 0.008 0.222 0.05 0.046 0.012 0.235   
86 0.276 0.009 0.143 0.003 0.254 0.014 0.136 0.007 0.245   
87 0.243 0.047 0.013 0.003 0.241 0.057 0.008 0.003 0.263   
88 0.221 0.057 0.117 0.045 0.216 0.041 0.245 0.103 0.22   
89 0.284 0.067 0.033 0 0.368 0 0.029 0.015 0.331   
90 0.221 0.037 0.443 0.017 0.219 0.01 0.478 0.019 0.217   
91 0.22 0.071 0.001 0 0.178 0.094 0.004 0.001 0.226   
92 0.224 0.007 0.028 0.003 0.21 0.012 0.095 0.015 0.22   
93 0.197 0.007 0.197 0.032 0.2 0.011 0.515 0.054 0.205   
94 0.202 0.012 0.477 0.144 0.207 0.021 0.109 0.045 0.196   
95 0.225 0.009 0.334 0.013 0.219 0.004 0 4.006 0.198   
96 0.239 0.03 0.034 0.002 0.237 0.021 0.016 0.002 0.238   
97 0.296 0.08 0.015 0.007 0.254 0.086 0.087 0.014 0.218 0.021 0.015 
98 0.006 0.211 0 0.118 0.011 0.215 0 0.085 0.01 0.207 0 
99 0.23 0.007 0.131 0.005 0.255 0.012 0.417 0.031 0.254 0.008 0.254 
100 0.214 0.021 0.018 0.003 0.228 0.028 0.075 0.006 0.227 0.01 0.01 
 0.229 0.062 0 5.68 0.189 0.083 0 0 0.222 0.127 0.153 
 
 
slno 
1 heelsda heelpt heelsdt halluxpa1 halluxsda1 halluxpt1 halluxsdt1 medialpa1 medialsda1 
2 0.448 0.273 0.062 0.016 0.006 0.271 0.072 0.179 0.079 
3 0.004 0.226 0.04 0.467 0.034 0.194 0.009 0.129 0.01 
4 0.013 0.216 0.014 0.264 0.044 0.31 0.078 0.069 0.014 
5 0.001 0.282 0.098 0.099 0.015 0.251 0.05 0.009 0.003 
6 0.004 0.228 0.018 0.006 5.23 0.024 0.105 0.077 0.004 
7 0.006 0.263 0.055 0.958 0.041 0.218 0.005 0.095 0.008 
8 0.027 0.21 0.027 0.11 0.011 0.274 0.06 0.048 0.006 
9 0.008 0.198 0.04 0.031 0.021 0.169 0.006 0.017 0.006 
10 0.001 0.232 0.05 0.284 0.023 0.241 0.058 0.144 0.001 
11 0.241 0.292 0.07 0.027 0.007 0.212 0.017 0.099 0.013 
12 0.012 9.233 0.003 0.594 0.049 0.208 0.002 0.014 0.003 
13 0.002 0.209 0.519 1.103 0.105 0.211 0.003 0.3 0.018 
14 0.002 0.239 0.025 0.081 0.013 0.237 0.029 0.223 0.004 
15 0.009 0.227 0.045 0.069 0.004 0.18 0.004 0.08 0.006 
16 0.004 0.199 0.006 0.029 0.012 0.228 0.05 0.062 0.015 
17 0.003 0.234 0.013 0.089 0.004 0.208 0.006 0.083 0.006 
18 0 0.254 0.067 1.044 0.299 0.171 0.017 0.474 0.032 
19 0.048 0.199 0.011 1.157 0.132 0.171 0.003 0.059 0.001 
20 0.009 0.206 0.049 0.67 0.225 0.22 0.055 0.722 0.834 
127 
 
21 0.011 0.236 0.073 0.452 0.022 0.195 0.994 0.127 0.013 
22 0.024 0.295 0.028 0.529 0.034 0.256 0.018 0.1 0.013 
23 0.003 0.209 0.005 0.071 0.008 0.226 0.007 0.024 0.005 
24 0.003 0.284 0.074 0.069 0.028 0.258 0.057 0.037 0.031 
25 0.003 0.209 0.034 0.327 0.02 0.183 0.033 0.007 0.001 
26 0.005 0.231 0.048 0.081 0.009 0.228 0.069 0.129 0.015 
27 5.08 0.275 0.1 0.012 0.003 0.259 0.101 0.114 0.028 
28 0.002 0.229 0.005 0.594 0.038 0.178 0.003 0.135 0.011 
29 0.017 0.225 0.01 0.139 0.003 0.249 0.097 0.082 0.02 
30 0.006 0.263 0.028 0.202 0.008 0.202 0.007 0.074 0.01 
31 0 0.22 0.01 0.309 0.027 0.251 0.009 0.049 0.006 
32 0.001 0.27 0.043 0.234 0.014 0.236 0.008 0.015 0.001 
33 0.01 0.204 0.037 0.74 0.026 0.195 0.002 0.2 0.014 
34 0.017 0.269 0.056 0 6.366 0.239 0.099 0.117 0.03 
35 0.01 0.269 0.044 0.353 0.027 0.234 0.006 0.073 0.01 
36 0.006 0.232 0.042 0.344 0.037 0.187 0.009 0.15 0.019 
37 0.003 0.259 0.059 0.477 0.022 0.217 0.006 0.045 0.009 
38 0.006 0.296 0.005 0.134 0.019 0.27 0.063 0.238 0.014 
39 0.011 0.208 0.088 0.139 0.009 0.253 0.061 0.089 0.012 
40 0.006 0.2 0.006 0.561 0.035 0.175 0.005 0.128 0.124 
41 0 0.23 0.094 0.016 0.003 0.229 0.032 0.005 0.001 
42 0.003 0.221 0.047 0.065 0.008 0.188 0.019 0.009 0.003 
43 0.013 0.211 0.002 0.147 0.003 0.248 0.072 0.139 0.011 
44 0.002 0.254 0.05 0.008 0.004 0.254 0.059 0.005 0.001 
45 0.006 0.268 0.054 0.808 0.09 0.297 0.047 0.624 0.108 
46 0.005 0.231 0.048 0.082 0.055 0.261 0.06 0.013 0.002 
47 0 0.185 0.061 0.019 0.003 0.247 0.028 0.021 0.003 
48 0.005 0.249 0.03 0.273 0.02 0.23 0.002 0.118 0.012 
49 0 0.28 0.063 0.119 0.011 0.212 0.005 0.048 0.003 
50 0.036 0.247 0.077 0.235 0.068 0.281 0.072 0.134 0.061 
51 0.002 0.156 0.063 0.001 0 0.185 0.072 0.011 0.004 
52 0.007 0.207 0.003 0.393 0.023 0.225 0.005 0.103 0.006 
53 0.001 0.253 0.067 0.114 0.038 0.271 0.362 0.01 0.002 
54 0.002 0.237 0.019 0.505 0.035 0.22 0.006 0.155 0.022 
55 0.011 0.21 0.007 0.076 0.006 0.231 0.018 0.057 0.005 
56 0.124 0.323 0.089 1.435 0.05 0.221 0.005 0.413 0.025 
57 0.009 0.245 0.042 0.128 0.006 0.224 0.007 0.034 0.008 
58 0.004 0.389 0.007 0.314 0.082 0.343 0.089 0.146 0.025 
59 0.003 0.239 0.049 0.126 0.012 0.23 0.058 0.281 0.014 
60 0.003 0.294 0.027 0.029 0.007 0.337 0.046 0.019 0.006 
61 0 0.245 0.027 0.283 0.003 0.203 0.005 0.006 0.002 
62 0.003 0.218 0.047 0.593 0.029 0.208 0.005 0.098 0.007 
63 0.012 0.206 0.049 0.147 0.012 0.227 0.07 0.143 0.003 
64 0.004 0.21 0.015 0.065 0.007 0.239 0.044 0.044 0.004 
65 0.014 0.215 0.009 0.371 0.038 0.182 0.003 0.004 0.001 
128 
 
66 0.004 0.235 0.029 0.145 0.003 0.236 0.027 0.118 0.008 
67 0.004 0.222 0.049 1.442 0.009 0.195 0.006 0.143 0.003 
68 0.004 0.262 0.086 0.104 0.011 0.352 0.011 0.102 0.009 
69 0.005 0.241 0.016 1.748 0.058 0.233 0.006 0.012 0.002 
70 0.003 0.204 0.008 0.059 0.002 0.201 0.004 0.046 0.003 
71 0.005 0.228 0.01 1.086 0.032 0.197 0.006 0.147 0.003 
72 0 0.258 0.037 0.546 0.073 0.202 0.004 0.028 0.004 
73 0.001 0.229 0.064 0.128 0.015 0.172 0.007 0.012 0.002 
74 0.001 0.227 0.033 0.258 0.008 0.245 0.007 0.013 0 
75 0.029 0.251 0.01 0.142 0.007 0.281 0.043 0.075 0.014 
76 0.005 0.228 0.035 0.837 0.016 0.193 0.003 0.041 0.005 
77 0.002 0.217 0.004 0.262 0.026 0.205 0.003 0.075 0.01 
78 0.002 0.247 0.052 0.036 0.007 0.256 0.027 0.017 0.003 
79 0 0.24 0.017 0.287 0.006 0.273 0.034 0.014 0 
80 0.01 0.255 0.006 0.666 0.025 0.23 0.005 0.448 0.025 
81 0.001 0.22 0.014 1.466 0.168 0.208 0.009 0.041 0.006 
82 0 0.268 0.031 0.288 0.004 0.245 0.015 0.015 0 
83 0.005 0.232 0.003 1.258 0.115 0.236 0.008 0.659 0.065 
84 0.082 0.23 0.01 1.318 0.117 0.232 0.002 0.01 0.005 
85 0.005 0.281 0.097 0.806 0.036 0.16 0.002 0.088 0.01 
86 0.001 0.247 0.152 0.267 0.013 0.261 0.006 0.139 0.001 
87 0.001 0.229 0.046 0.264 0.016 0.251 0.005 0.042 0.003 
88 0.051 0.208 0.044 0.114 0.032 0.202 0.035 0.046 0.021 
89 0.013 0.267 0.051 0.046 0.012 0.243 0.059 0.011 0.003 
90 0.018 0.231 0.066 0.859 0.034 0.21 0.003 0.328 0.045 
91 0.001 0.197 0.04 0.547 0.059 0.192 0.011 0.137 0.022 
92 0.002 0.232 0.035 0.169 0.01 0.261 0.015 0.014 0.001 
93 0.006 0.211 0.024 0.543 0.047 0.223 0.105 0.41 0.052 
94 0.031 0.205 0.02 0.372 0.019 0.192 0.011 0.024 0.007 
95 0.005 0.244 0.039 1.094 0.104 0.225 0.004 0.325 0.027 
96 0.003 0.247 0.014 0.124 0.003 0.21 0.003 0.031 0.005 
97 0.009 0.243 0.095 0.265 0.022 0.227 0.019 0.084 0.031 
98 0.069 0.007 0.211 0 0.072 0.015 0.203 0 0.11 
99 0.031 0.24 0.021 0.141 0.001 0.247 0.008 0.074 0.008 
100 0.003 0.244 0.094 0.29 0.047 0.214 0.016 0.035 0.014 
 0.005 0.21 0.005 0.872 0.021 0.219 0.004 0.341 0.007 
 
slno 
1 middlepa1 middlesda1 middlept1 middlesdt1 laterffpa1 laterffsd1 laterffpt1 laterffsd2 latermfpa1 latermfsd1 
2 0.094 0.045 0.278 0.091 0.058 0.023 0.255 0.076 0.087 0.046 
3 0.126 0.011 0.228 0.055 0.013 0.001 0.21 0.041 0.377 0.065 
4 0.029 0.009 0.36 0.032 0.024 0.008 0.343 0.059 0.061 0.015 
5 0.015 0.001 0.255 0.074 0.007 0.002 0.264 0.074 0.004 0.002 
6 0.005 0.003 0.201 0.005 0.074 0.004 0.21 0.004 0.035 0.003 
7 0.079 0.005 0.259 0.058 0.391 0.017 0.213 0.006 0 3.288 
129 
 
8 0.016 0.004 0.314 0.065 0.016 0.009 0.295 0.071 0.023 0.014 
9 0.005 0.003 0.297 0.101 0.006 0.002 0.207 0.066 0.268 0.02 
10 0.065 0.017 0.231 0.032 0.125 0.015 0.231 0.049 0.047 0.013 
11 0.134 0.021 0.21 0.004 0.66 0.021 0.203 0.01 0.157 0.042 
12 0.008 0.002 0.261 0.088 0.008 0.002 0.239 0.082 0.011 0.003 
13 0.029 0.006 0.216 0.04 0.052 0.001 0.237 0.013 0.773 0.12 
14 0.017 0.005 0.242 0.052 0.01 0.005 0.22 0.046 0.012 0.003 
15 0.024 0.003 0.201 0.02 0.071 0.004 0.197 0.007 0.106 0.012 
16 0.114 0.017 0.206 0.007 0.01 0.006 0.264 0.075 0.044 0.005 
17 0.051 0.005 0.222 0.009 0.047 0.006 0.22 0.007 0.067 0.007 
18 0.312 0.043 0.19 0.028 0.153 0.002 0.288 0.102 0.199 0.04 
19 0.058 0.003 0.222 0.028 0.03 0.001 0.255 0.04 0.051 0.138 
20 0.346 0.302 0.198 0.039 0.627 0.407 0.291 0.063 0.37 0.444 
21 0.012 0.003 0.256 0.066 0.029 0.001 0.211 0.072 0.16 0.013 
22 0.045 0.019 0.285 0.096 0.052 0.015 0.275 0.071 0.068 0.017 
23 0.079 0.009 0.219 0.018 0.015 0 0.223 0.084 0.071 0.008 
24 0.036 0.017 0.27 0.072 0.02 0.013 0.243 0.054 0.124 0.113 
25 0.039 0.003 0.195 0.01 0.015 0.001 0.229 0.074 0.028 0.002 
26 0.113 0.017 0.215 0.006 0.131 0.011 0.202 0.005 0.024 0.01 
27 0.094 0.028 0.225 0.023 0.1 0.03 0.208 0.024 0.109 0.031 
28 0.036 0.007 0.205 0.057 0.046 0.01 0.252 0.081 0.061 0.003 
29 0.053 0.009 0.295 0.064 0.137 0.006 0.223 0.089 0.314 0.224 
30 0.032 0.004 0.285 0.037 0.02 0.003 0.28 0.066 0.043 0.008 
31 0.035 0.005 0.257 0.035 0.061 0.007 0.247 0.047 0.033 0.005 
32 0.128 0.017 0.251 0.012 0.112 0.014 0.245 0.012 0.036 0.007 
33 0.029 0.001 0.263 0.04 0.029 0.001 0.271 0.041 0.409 0.025 
34 0 7.25 0.209 0.071 0 7.571 0.256 0.118 0.078 0.031 
35 0.029 0.003 0.268 0.037 0 5.079 0.206 0.073 0.139 0.003 
36 0.039 0.009 0.219 0.053 0.087 0.011 0.19 0.01 0.085 0.011 
37 0.085 0.012 0.207 0.009 0.134 0.005 0.227 0.009 0.332 0.023 
38 0.277 0.006 0.258 0.025 0.107 0.004 0.253 0.008 0.174 0.012 
39 0.053 0.009 0.22 0.012 0.13 0.014 0.237 0.024 0.301 0.039 
40 0.057 0.006 0.181 0.013 0.128 0.01 0.179 0.004 0.138 0.017 
41 0.004 0.002 0.274 0.079 0.003 0.001 0.251 0.101 0.004 0.002 
42 0.015 0.003 0.237 0.067 0.143 0.007 0.207 0.013 0.13 0.013 
43 0.1 0.019 0.189 0.005 0.125 0.01 0.193 0.005 0.166 0.013 
44 0.007 0.003 0.236 0.044 0.005 0.002 0.235 0.063 0.006 0.003 
45 0.029 0.004 0.303 0.059 0.058 0 0.222 0.004 0.058 0.001 
46 0.039 0.003 0.203 0.011 0.059 0.002 0.195 0.008 0.109 0.013 
47 0.081 0.011 0.223 0.011 0.065 0.006 0.234 0.006 0.177 0.014 
48 0.04 0.004 0.244 0.007 0.949 0.003 0.224 0.007 0.117 0.009 
49 0.013 0.003 0.217 0.059 0.06 0.005 0.216 0.009 0.102 0.008 
50 0 0.601 0.226 0.098 0.16 0.075 0.234 0.071 0.123 0.052 
51 0.007 0.002 0.206 0.114 0.005 0.002 0.247 0.086 0.007 0.002 
52 0.147 0.009 0.221 0.004 0.23 0.011 0.226 0.005 0.074 0.008 
130 
 
53 0.148 0.033 0.278 0.048 0.041 0.024 0.264 0.074 0.092 0.041 
54 0.11 0.012 0.239 0.011 0.176 0.012 0.226 0.007 0.095 0.012 
55 0.028 0.002 0.246 0.021 0.047 0.005 0.227 0.044 0.201 0.028 
56 0.032 0.009 0.259 0.067 0.15 0.018 0.23 0.009 0.216 0.015 
57 0.022 0.007 0.208 0.038 0.071 0.004 0.203 0.007 0.055 0.003 
58 0.152 0.008 0.385 0.008 0.113 0.011 0.39 0.009 0.32 0.007 
59 0.124 0.008 0.226 0.039 0.273 0.015 0.21 0.006 0.26 0.012 
60 0.015 0.005 0.298 0.044 0.024 0.01 0.302 0.051 0.022 0.006 
61 0.273 0.017 0.223 0.006 0.14 0.004 0.218 0.02 0.08 0.007 
62 0.07 0.031 0.199 0.015 0.004 0.001 0.178 0.054 0.005 0.001 
63 0.077 0.014 0.196 0.028 0.032 0.005 0.195 0.038 0.397 0.051 
64 0.029 0.004 0.223 0.023 0.351 0.012 0.215 0.002 0.389 0.029 
65 0.017 0.005 0.184 0.018 0.028 0.007 0.181 0.012 0.013 0.005 
66 0.103 0.009 0.251 0.043 0.135 0.005 0.244 0.008 0.094 0.007 
67 0.057 0.002 0.27 0.093 0.057 0.001 0.193 0.051 0.098 0.005 
68 0.028 0.003 0.349 0.018 0 5.745 0.27 0.059 5.29 1.57 
69 0.012 0.001 0.238 0.027 0.005 0 0.257 0.032 0.302 0.038 
70 0.009 0.002 0.199 0.029 0.053 0.004 0.207 0.009 0.096 0.006 
71 0.039 0.008 0.218 0.03 0.059 0.001 0.286 0.082 0.388 0.015 
72 0.052 0.003 0.209 0.007 0.045 0.004 0.198 0.007 0.014 0.001 
73 0.007 0.002 0.195 0.043 0.02 0.002 0.179 0.011 0.012 0.006 
74 0.104 0.006 0.267 0.035 0.136 0.002 0.245 0.006 0.249 0.019 
75 0.078 0.011 0.227 0.009 0.069 0.011 0.226 0.01 0.112 0.015 
76 0.019 0.004 0.199 0.025 0.032 0.012 0.222 0.043 0.066 0.011 
77 0.014 0.003 0.237 0.025 0.06 0.002 0.263 0.07 0.133 0.013 
78 0.037 0.006 0.248 0.024 0.023 0.004 0.235 0.023 0.082 0.015 
79 0.553 0.015 0.229 0.008 0.144 0.004 0.273 0.028 0.17 0.039 
80 0.226 -0.025 0.235 0.02 0.626 0.025 0.222 0.003 0.571 0.022 
81 0.102 0.019 0.22 0.045 0.144 0.007 0.265 0.047 0.053 0.013 
82 0.125 0.006 0.198 0.004 0.146 0.002 0.242 0.003 0.285 0.004 
83 0.028 0.002 0.249 0.062 0.028 0.003 0.236 0.058 0.352 0.057 
84 0.02 0.009 0.272 0.072 0.008 0.003 0.237 0.083 0.065 0.012 
85 0.029 0.004 0.179 0.024 0.053 0.007 0.195 0.047 0.071 0.01 
86 0.203 0.01 0.265 0.004 0.125 0.006 0.246 0.007 0.11 0.005 
87 0.017 0.005 0.249 0.027 0.025 0.002 0.253 0.023 0.012 0.004 
88 0.025 0.009 0.261 0.089 0.014 0.005 0.246 0.078 0.047 0.013 
89 0.014 0.002 0.227 0.038 0.021 0.006 0.192 0.033 0.02 0.004 
90 0.022 0.003 0.298 0.122 0.028 0.002 0.249 0.05 0.065 0.005 
91 0.028 0.006 0.25 0.067 0.041 0.012 0.255 0.077 0.059 0.002 
92 0.083 0.007 0.282 0.026 0.112 0.012 0.267 0.028 0.125 0.008 
93 0.193 0.042 0.224 0.055 0.134 0.029 0.212 0.033 0.351 0.086 
94 0.048 0.01 0.203 0.036 0.518 0.016 0.186 0.005 0.163 0.02 
95 0.216 0.015 0.23 0.007 0.088 0.007 0.225 0.009 0 3.353 
96 0.03 0.003 0.22 0.02 0.098 0.005 0.199 0.005 0.064 0.002 
97 0.086 0.029 0.214 0.037 0.011 0.003 0.227 0.078 0.142 0.011 
131 
 
98 0 0.024 0.005 0.201 0 0.144 0.007 0.219 0 0.102 
99 0.046 0.007 0.221 0.019 0.141 0.002 0.244 0.007 0.363 0.02 
100 0.032 0.031 0.203 0.043 0.006 0.003 0.232 0.064 0.004 0.002 
 0.336 0.006 0.268 0.078 0 1.807 0.261 0.057 9.4 3.189 
 
slno latermfsd2 heelpa1 heelsda1 heelpt1 heelsdt1 halluxpa2 halluxsda2 halluxpt2 halluxsdt2 
1 0.077 0.135 0.075 0.272 0.053 1.052 0.04 0.242 0.003 
2 0.041 0.118 0.013 0.222 0.02 0.337 0.027 0.201 0.007 
3 0.088 0.028 0.009 0.354 0.067 0.67 0.118 0.207 0.005 
4 0.062 0.002 0 0.255 0.088 0.108 0.034 0.223 0.005 
5 0.007 0.041 0.003 0.215 0.012 9.784 5.515 0.295 0.088 
6 0.072 0.068 0.004 0.223 0.019 0.735 0.229 0.214 0.005 
7 0.055 0.016 0.015 0.297 0.066 0.456 0.041 0.241 0.059 
8 0.005 0.062 0.007 0.18 0.028 0.295 0.017 0.167 0.003 
9 0.031 0.008 0.003 0.236 0.053 0.293 0.006 0.229 0.015 
10 0.008 0.012 0.002 0.209 0.029 0.024 0.011 0.238 0.09 
11 0.052 0.008 0.003 0.252 0.072 0.583 0.03 0.216 0.002 
12 0.003 0.102 0.005 0.213 0.006 0.569 0.141 0.195 0.012 
13 0.03 0.009 0.005 0.273 0.063 0.31 0.054 0.24 0.013 
14 0.006 0 4.529 0.201 0.093 0.123 0.004 0.182 0.005 
15 0.012 0.017 0.004 0.208 0.027 0.222 0.068 0.214 0.026 
16 0.008 0.024 0.004 0.214 0.01 0.109 0.012 0.216 0.013 
17 0.084 0.01 0.01 0.238 0.075 1.233 0.051 0.18 0.004 
18 0.057 0.051 0.01 0.185 0.045 1.227 0.162 0.165 0.008 
19 0.054 0.138 0.118 0.168 0.023 0.575 0.08 0.18 0.01 
20 0.011 0.013 0.002 0.227 0.053 0.453 0.022 0.197 0.004 
21 0.064 0.068 0.048 0.269 0.088 0.654 0.046 0.22 0.013 
22 0.007 0.139 0.007 0.221 0.186 0.737 0.025 0.199 0.003 
23 0.076 0.079 0.04 0.273 0.066 0.043 0.013 0.243 0.04 
24 0.01 0.037 0.003 0.191 0.007 0.256 0.018 0.157 0.004 
25 0.056 0.003 0.001 0.211 0.064 0.113 0.026 0.378 0.027 
26 0.021 0.065 0.013 0.215 0.014 0.109 0.024 0.199 0.015 
27 0.007 0.075 0.004 0.183 0.006 0.2 0.013 0.162 0.005 
28 0.062 0.202 0.014 0.252 0.023 0.14 0.004 0.221 0.074 
29 0.039 0.12 0.008 0.263 0.008 0.336 0.017 0.217 0.005 
30 0.017 0.021 0.002 0.251 0.063 0.298 0.143 0.244 0.04 
31 0.033 0.027 0.003 0.249 0.064 0.24 0.058 0.241 0.045 
32 0.002 0.257 0.009 0.201 0.002 0.048 0.041 0.262 0.081 
33 0.065 0.142 0.029 0.269 0.055 0.001 0 0.215 0.09 
34 0.061 0.081 0.016 0.248 0.009 0.457 0.04 0.255 0.008 
35 0.142 0.018 0.003 0.205 0.033 0.236 0.266 0.187 0.008 
36 0.007 0.028 0.001 0.269 0.035 0.474 0.038 0.209 0.006 
37 0.007 0.082 0.005 0.252 0.01 0.03 0.01 0.278 0.066 
38 0.005 0 0 0.235 0.092 0.144 0.007 0.243 0.059 
39 0.005 0.089 0.007 0.182 0.005 0.462 0.068 0.167 0.005 
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40 0.087 0.002 0.001 0.246 0.083 0.045 0.02 0.269 0.036 
41 0.011 0.011 0.003 0.201 0.043 0.072 0.03 0.227 0.067 
42 0.004 0.073 0.007 0.188 0.004 0.147 0.007 0.281 0.104 
43 0.072 0.009 0.002 0.269 0.089 0.258 0.017 0.25 0.01 
44 0.006 0.039 0.001 0.227 0.008 2.217 0.132 0.262 0.012 
45 0.006 0.006 0.001 0.206 0.035 0.044 0.025 0.244 0.046 
46 0.004 0.022 0.002 0.235 0.028 0.009 0.001 0.218 0.066 
47 0.006 0.087 0.005 0.225 0.006 0.314 0.023 0.209 0.002 
48 0.006 7.854 2.88 0.152 0.07 0.135 0.011 0.2 0.017 
49 0.061 0.187 0.023 0.264 0.017 0.666 0.08 0.234 0.012 
50 0.087 0.006 0.001 0.259 0.081 0 0 0.294 0.122 
51 0.01 0.083 0.003 0.226 0.005 0.41 0.028 0.227 0.005 
52 0.07 0.021 0.003 0.205 0.015 0.046 0.017 0.288 0.038 
53 0.009 0.015 0.004 0.276 0.028 0.272 0.056 0.22 0.017 
54 0.004 0.061 0.004 0.201 0.007 0.193 0.049 0.231 0.007 
55 0.005 0.037 0.014 0.321 0.068 1.047 0.083 0.22 0.006 
56 0.008 0.048 0.003 0.221 0.008 0.075 0.006 0.193 0.05 
57 0.011 0.074 0.002 0.387 0.013 0.6 0.038 0.381 0.007 
58 0.007 0.021 0.003 0.242 0.05 0.433 0.06 0.22 0.022 
59 0.093 0.01 0.005 0.312 0.064 0.068 0.009 0.181 0.021 
60 0.011 0.027 0.002 0.227 0.049 0.286 0.007 0.212 0.034 
61 0.073 0.004 0.001 0.18 0.057 0.235 0.029 0.261 0.074 
62 0.021 0.063 0.011 0.216 0.037 0.144 0.008 0.193 0.061 
63 0.002 0.094 0.005 0.221 0.004 0.024 0.006 0.257 0.066 
64 0.066 0.03 0.01 0.187 0.015 0.371 0.051 0.171 0.006 
65 0.006 0.066 0.01 0.246 0.006 0.139 0.014 0.243 0.026 
66 0.024 0.143 0.002 0.213 0.012 1.997 0.069 0.205 0.01 
67 0.05 0.001 0 0.347 0.018 0.692 0.021 0.194 0.04 
68 0.006 0.082 0.005 0.242 0.017 1.065 0.088 0.208 0.006 
69 0.003 0.024 0.002 0.197 0.008 0.111 0.006 0.187 0.002 
70 0.004 0.127 0.008 0.219 0.009 0.488 0.032 0.174 0.012 
71 0.004 0.001 2.89 0.193 0.004 0.63 0.097 0.208 0.032 
72 0.044 0.009 0.002 0.207 0.034 0.119 0.009 0.172 0.008 
73 0.008 0.027 0.001 0.239 0.01 0.218 0.039 0.251 0.035 
74 0.009 0.072 0.011 0.219 0.009 0.138 0.009 0.307 0.064 
75 0.009 0.022 0.003 0.194 0.018 0.982 0.014 0.184 0.004 
76 0.008 0.007 0.001 0.244 0.066 0.628 0.057 0.187 0.004 
77 0.017 0.013 0.004 0.285 0.067 0.047 0.04 0.278 0.075 
78 0.029 0.029 0.001 0.269 0.03 0.278 0.008 0.254 0.007 
79 0.002 0.001 0 0.276 0.078 1.182 0.214 0.212 0.011 
80 0.053 0.006 0.001 0.228 0.062 1.215 0.296 0.22 0.008 
81 0.003 0.029 0.001 0.248 0.005 0.193 0.022 0.2 0.009 
82 0.009 0.139 0.007 0.229 0.018 0.555 0.055 0.221 0.009 
83 0.014 0.143 0.014 0.223 0.007 1.185 0.103 0.222 0.009 
84 0.008 0.022 0.004 0.198 0.019 1.038 0.022 0.161 0.003 
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85 0.012 0.025 0.001 0.269 0.051 0.207 0.027 0.254 0.008 
86 0.06 0.015 0.002 0.247 0.022 0.295 0.061 0.231 0.004 
87 0.082 0.041 0.017 0.292 0.046 0.312 0.222 0.216 0.067 
88 0.02 0.003 0.002 0.25 0.078 0.229 0.046 0.184 0.019 
89 0.041 0.028 0.003 0.265 0.072 1.612 0.067 0.228 0.003 
90 0.077 0.059 0.003 0.249 0.054 0.379 0.131 0.237 0.064 
91 0.017 0.029 0.001 0.282 0.042 0.029 0.013 0.292 0.039 
92 0.026 0.123 0.033 0.214 0.032 0.517 0.085 0.183 0.038 
93 0.004 0.127 0.007 0.189 0.007 0.24 0.117 0.173 0.007 
94 0.106 0.142 0.018 0.225 0.005 0.694 0.15 0.242 0.011 
95 0.011 0.005 0.004 0.216 0.009 0.073 0.009 0.205 0.015 
96 0.006 0.009 0.004 0.256 0.089 0.287 0.009 0.234 0.044 
97 0.201 0 0.056 0.008 0.205 0 0.128 0.031 0.193 
98 0.005 0.336 0.012 0.209 0.004 0.14 0.003 0.243 0.009 
99 0.074 0.005 0.003 0.264 0.092 0.087 0.041 0.264 0.044 
100 0.083 0.169 0.006 0.225 0.004 0.179 0.014 0.193 0.002 
 
slno medialpt2 medialsdt2 middlepa2 middlesda2 middlept2 middlesdt2 laterffpa2 laterffsd3 laterffpt2 
1 0.243 0.003 0.133 0.006 0.25 0.005 0.066 0.004 0.237 
2 0.229 0.031 0.124 0.005 0.222 0.01 0.011 0.012 0.215 
3 0.21 0.004 0.067 0.026 0.24 0.06 0.212 0.046 0.21 
4 0.24 0.034 0.026 0.011 0.27 0.059 0.003 0.001 0.286 
5 0.199 0.007 0.048 0.005 0.193 0.009 0.047 0.004 0.196 
6 0.206 0.006 0.35 0.057 0.219 0.009 0.541 0.051 0.214 
7 0.199 0.005 0.131 0.011 0.27 0.068 0.125 0.009 0.189 
8 0.211 0.051 0.131 0.022 0.176 0.012 0.077 0.004 0.157 
9 0.236 0.03 0.124 0.008 0.202 0.029 0.146 0.004 0.228 
10 0.242 0.081 0.009 0.004 0.247 0.096 0.002 0.001 0.2 
11 0.248 0.063 0.01 0.006 0.249 0.043 0.008 0.002 0.253 
12 0.22 0.025 0.048 0.01 0.227 0.041 0.033 0.021 0.238 
13 0.239 0.025 0.087 0.035 0.261 0.051 0.049 0.023 0.242 
14 0.189 0.007 0.096 0.019 0.185 0.012 0.132 0.017 0.214 
15 0.27 0.05 0.099 0.013 0.213 0.011 0.038 0.014 0.222 
16 0.206 0.009 0.005 0.002 0.266 0.061 0.007 0.002 0.303 
17 0.186 0.007 0.158 0.017 0.185 0.011 0.435 0.02 0.18 
18 0.233 0.042 0.057 0.005 0.227 0.057 0.028 0.002 0.228 
19 0.197 0.026 0.181 0.07 0.192 0.039 0.245 0.029 0.175 
20 0.194 0.007 0.029 0.002 0.21 0.081 0.028 0 0.171 
21 0.213 0.013 0.351 0.02 0.212 0.009 0.226 0.015 0.226 
22 0.208 0.008 0.149 0.004 0.232 0.045 0.15 0 0.288 
23 0.234 0.023 0.029 0.009 0.248 0.04 0.062 0.012 0.229 
24 0.161 0.02 0.013 0.005 0.171 0.055 0.012 0.002 0.219 
25 0.274 0.043 0.099 0.038 0.314 0.048 0.148 0.052 0.241 
26 0.209 0.062 0.096 0.047 0.238 0.056 0.229 0.012 0.234 
27 0.194 0.077 0.013 0.003 0.301 0.085 0.005 0.001 0.221 
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28 0.184 0.029 0.029 0.008 0.183 0.007 0.061 0.024 0.189 
29 0.238 0.065 0.056 0.016 0.215 0.031 0.158 0.044 0.221 
30 0.24 0.03 0.023 0.004 0.251 0.046 0.038 0.005 0.234 
31 0.135 0.004 0.177 0.075 0.288 0.076 0.067 0.014 0.211 
32 0.286 0.055 0.006 0.004 0.279 0.086 0.005 0.003 0.286 
33 0.256 0.003 0.344 0.012 0.261 0.003 0.001 0 0.192 
34 0.29 0.069 0.179 0.005 0.269 0.061 0 4.305 0.209 
35 0.188 0.027 0.062 0.01 0.176 0.012 0.021 0.009 0.204 
36 0.308 0.074 0.333 0.058 0.196 0.016 0.005 0.002 0.276 
37 0.267 0.061 0.126 0.492 0.276 0.067 0.138 0.008 0.227 
38 0.237 0.058 0.212 0.066 0.2 0.006 0.048 0.027 0.218 
39 0.169 0.014 0.175 0.085 0.17 0.033 0.401 0.073 0.16 
40 0.281 0.066 0.005 0.003 0.238 0.077 0.003 0.001 0.229 
41 0.199 0.112 0.14 0.085 0.199 0.076 0.019 0.004 0.244 
42 0.22 0.075 0.244 0.03 0.18 0.013 0.124 0.006 0.17 
43 0.248 0.003 0.259 0.006 0.245 0.003 0.195 0.006 0.235 
44 0.28 0.012 0.014 0.004 0.318 0.074 0.059 0.001 0.254 
45 0.231 0.045 0.024 0.002 0.212 0.01 0.046 0.003 0.205 
46 0.239 0.054 0.033 0.011 0.243 0.048 0.027 0.008 0.196 
47 0.215 0.003 0.117 0.007 0.219 0.004 0.116 0.022 0.212 
48 0.174 0.012 0.163 0.074 0.188 0.015 0.065 0.032 0.181 
49 0.246 0.034 0 5.334 0.256 0.109 0.017 0.005 0.266 
50 0.253 0.12 0.005 0.001 0.232 0.126 0.003 0.001 0.248 
51 0.225 0.003 0.102 0.008 0.215 0.006 0.391 0.035 0.221 
52 0.281 0.068 0.161 0.068 0.261 0.061 0.008 0.005 0.304 
53 0.222 0.015 0.048 0.027 0.237 0.032 0.117 0.037 0.223 
54 0.235 0.047 0.01 0.004 0.309 0.053 0.04 0.01 0.223 
55 0.218 0.005 0.374 0.023 0.221 0.004 0.436 0.054 0.217 
56 0.209 0.061 0.024 0.017 0.283 0.073 0.083 0.017 0.205 
57 0.363 0.018 0.038 0.005 0.374 0.016 0.166 0.013 0.388 
58 0.245 0.064 0.323 0.121 0.238 0.078 0.302 0.099 0.231 
59 0.297 0.059 0.036 0.005 0.304 0.04 0.131 0.005 0.246 
60 0.324 0.067 0.057 0.018 0.255 0.023 0.064 0.042 0.247 
61 0.247 0.074 0.029 0.003 0.244 0.073 0.012 0.002 0.293 
62 0.193 0.042 0.418 0.065 0.189 0.007 0.13 0.012 0.212 
63 0.243 0.052 0.013 0.005 0.249 0.048 0.005 0.003 0.263 
64 0.195 0.353 0.05 0.099 0.199 0.035 0.002 8.789 0.201 
65 0.272 0.051 0.004 0.001 0.282 0.085 0.004 0.001 0.262 
66 0.204 0.096 0.049 0.007 0.197 0.104 0.057 0.001 0.181 
67 0.211 0.023 0.393 0.009 0.199 0.041 0.32 0.009 0.206 
68 0.214 0.02 0.005 0.004 0.285 0.064 0.003 0.002 0.248 
69 0.184 0.003 0.003 0.001 0.192 0.066 0.002 0.001 0.238 
70 0.209 0.026 0.05 0.006 0.184 0.021 0.06 0.002 0.229 
71 0.193 0.02 0.72 0.022 0.201 0.014 0.122 0.01 0.221 
72 0.168 0.025 0.029 0.005 0.177 0.016 0.025 0.002 0.162 
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73 0.29 0.042 0.047 0.014 0.246 0.043 0.007 0.004 0.263 
74 0.249 0.037 0.41 0.031 0.227 0.006 0.126 0.012 0.241 
75 0.212 0.029 0.054 0.009 0.219 0.04 0.06 0.001 0.212 
76 0.265 0.072 0.06 0.003 0.247 0.073 0.06 0.001 0.242 
77 0.264 0.054 0.019 0.013 0.292 0.043 0.017 0.009 0.303 
78 0.257 0.006 0.353 0.048 0.209 0.006 0.136 0.006 0.247 
79 0.223 0.057 0.357 0.073 0.215 0.008 0.336 0.111 0.23 
80 0.3 0.069 0.402 0.086 0.233 0.045 0.093 0.031 0.227 
81 0.229 0.023 0.055 0.029 0.207 0.023 0.005 0.002 0.257 
82 0.227 0.005 0.016 0.005 0.214 0.034 0.027 0.003 0.27 
83 0.256 0.083 0.006 0.001 0.232 0.073 0.005 0.002 0.272 
84 0.17 0.02 0.017 0.003 0.232 0.076 0.055 0.004 0.199 
85 0.263 0.083 0.003 0.001 0.234 0.059 0.004 0.001 0.245 
86 0.229 0.006 0.035 0.007 0.231 0.012 0.023 0.003 0.233 
87 0.212 0.031 0.191 0.123 0.204 0.025 0.183 0.116 0.196 
88 0.178 0.02 0.069 0.012 0.185 0.034 0.076 0.013 0.177 
89 0.285 0.071 0.124 0.019 0.263 0.075 0.219 0.018 0.225 
90 0.192 0.03 0.037 0.013 0.234 0.078 0.056 0.01 0.269 
91 0.26 0.068 0.006 0.004 0.337 0.021 0.014 0.008 0.291 
92 0.248 0.079 0.311 0.113 0.25 0.07 0.275 0.077 0.217 
93 0.243 0.077 0.092 0.008 0.187 0.016 0.197 0.009 0.17 
94 0.248 0.022 0.162 0.063 0.237 0.011 0.121 0.042 0.252 
95 0.217 0.054 0.004 0.001 0.232 0.089 0.009 0.004 0.314 
96 0.219 0.007 0.076 0.016 0.242 0.045 0.045 0.004 0.215 
97 0.005 0.173 0 0.11 0.025 0.18 0 0.032 0.046 
98 0.287 0.096 0.028 0.004 0.298 0.048 0.117 0.012 0.27 
99 0.236 0.015 0.034 0.007 0.225 0.026 0.092 0.006 0.23 
100 0.211 0.049 0.119 0.006 0.2 0.003 9.718 3.472 0.213 
          
 
slno latermfsd3 latermfpt2 latermfsd4 heelpa2 heelsda2 heelpt2 heelsdt2 
1 0.005 0.241 0.005 0.042 0.002 0.243 0.009 
2 0.009 0.209 0.017 0.083 0.009 0.212 0.009 
3 0.044 0.211 0.004 0.138 0.011 0.22 0.004 
4 0.004 0.231 0.061 0.003 0.001 0.322 0.066 
5 0.008 0.2 0.02 0.003 0.001 0.257 0.075 
6 4.25 0.192 0.082 0 0 0.198 0.098 
7 0.022 0.212 0.015 0.212 0.015 0.22 0.039 
8 0.013 0.157 0.139 0.007 0.003 0.259 0.059 
9 0.004 0.188 0.003 0.003 0.001 0.222 0.087 
10 0.003 0.287 0.092 0 0 0.209 0.099 
11 0.002 0.271 0.066 0.006 0.002 0.228 0.056 
12 0.089 0.284 0.08 0.004 0.003 0.222 0.094 
13 0.05 0.235 0.023 0.056 0.008 0.229 0.012 
14 0.055 0.182 0.019 0 0 0.184 0.092 
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15 0.015 0.218 0.031 0.014 0.005 0.221 0.045 
16 0.007 0.214 0.037 0.003 0.001 0.269 0.072 
17 0.045 0.18 0.005 0.001 0 0.293 0.06 
18 0.044 0.192 0.453 0.16 0.024 0.194 0.057 
19 0.036 0.176 0.007 0.13 0.023 0.202 0.016 
20 0.016 0.191 0.005 0.003 0.001 0.22 0.072 
21 0.021 0.207 0.011 0.173 0.037 0.166 0.008 
22 0.01 0.191 0.006 0.123 0.005 0.188 0.009 
23 0.017 0.208 0.004 0.041 0.01 0.224 0.035 
24 0.003 0.17 0.019 0.02 0.004 0.162 0.022 
25 0.117 0.238 0.054 0.222 0.007 0.315 0.034 
26 0.044 0.235 0.05 0.004 0.001 0.254 0.084 
27 0.002 0.283 0.106 0.005 0.002 0.34 0.047 
28 0.015 0.254 0.055 0.389 0.071 0.253 0.014 
29 0.002 0.209 0.01 0.005 0.012 0.195 0.088 
30 0.003 0.232 0.011 0.015 0.002 0.217 0.01 
31 0.018 0.228 0.016 0.005 0.003 0.267 0.075 
32 0.038 0.237 0.048 0.012 0.008 0.266 0.068 
33 0.004 0.258 0.007 0.116 0.013 0.252 0.004 
34 0.025 0.241 0.076 0.081 0.01 0.239 0.019 
35 0.008 0.227 0.057 0.003 0.001 0.272 0.076 
36 0.014 0.217 0.056 0.023 0.006 0.247 0.06 
37 0.027 0.206 0.029 0.009 0.002 0.217 0.062 
38 0.002 0.227 0.074 0 5.82 0.161 0.069 
39 0.048 0.164 0.004 0.003 0.001 0.249 0.083 
40 0.002 0.269 0.07 0.003 0.001 0.215 0.082 
41 0.028 0.182 0.015 0.004 0.001 0.254 0.119 
42 0.033 0.167 0.053 0.005 0.003 0.235 0.083 
43 0.01 0.246 0.005 0.145 0.008 0.253 0.003 
44 0.001 0.221 0.007 0.058 0.001 0.241 0.058 
45 0.015 0.206 0.002 0.005 0.001 0.205 0.029 
46 0.02 0.198 0.005 2.183 8.357 0.247 0.094 
47 0.006 0.208 0.016 0.003 0.001 0.232 0.089 
48 0.005 0.281 0.072 9.582 3.101 0.211 0.082 
49 0.018 0.236 0.01 0.162 0.006 0.247 0.003 
50 0.001 0.273 0.099 0.009 0.001 0.223 0.05 
51 0.005 0.221 0.004 0.003 0.001 0.243 0.098 
52 0.019 0.276 0.028 0.004 0.002 0.284 0.073 
53 0.027 0.222 0.017 0.003 0 0.31 0.1 
54 0.047 0.203 0.011 0.037 0.009 0.197 0.014 
55 0.032 0.214 0.005 0.091 0.007 0.226 0.005 
56 0.025 0.18 0.007 0.004 0.001 0.222 0.075 
57 0.002 0.353 0.036 0.003 0.001 0.233 0.083 
58 0.033 0.207 0.014 0.003 0.001 0.232 0.089 
59 0.007 0.28 0.008 0.052 0.004 0.314 0.015 
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60 0.023 0.215 0.019 0.029 0.001 0.194 0.039 
61 0.004 0.226 0.046 0.01 0.001 0.248 0.07 
62 0.027 0.181 0.021 0.005 0.001 0.226 0.064 
63 0.006 0.263 0.057 0.004 0.003 0.227 0.069 
64 0.024 0.188 0.026 0.006 0.002 0.305 0.086 
65 0.001 0.246 0.099 0.004 0.001 0.232 0.077 
66 0.008 0.241 0.046 0.004 0.002 0.27 0.071 
67 0.022 0.205 0.033 0.397 0.018 0.193 0.041 
68 0.03 0.209 0.012 0.004 0.001 0.212 0.031 
69 0.001 0.266 0.088 0.002 0.001 0.305 0.073 
70 0.027 0.177 0.002 0.095 0.013 0.184 0.007 
71 0 0.197 0.022 2.961 1.344 0.269 0.067 
72 0.002 0.162 0.024 0.003 0.001 0.282 0.112 
73 0.003 0.252 0.088 0.002 0.001 0.211 0.052 
74 0.056 0.224 0.006 0.255 0.024 0.223 0.003 
75 0.002 0.177 0.008 0.003 0.002 0.289 0.101 
76 0.005 0.178 0.008 0.004 0.001 0.258 0.082 
77 0.03 0.218 0.021 0.01 0.006 0.26 0.066 
78 0.017 0.238 0.012 0.027 0.001 0.254 0.014 
79 0.01 0.228 0.027 0.001 0 0.282 0.062 
80 0.081 0.228 0.037 0.027 0.004 0.267 0.069 
81 0.002 0.236 0.101 0.002 0.001 0.199 0.078 
82 0.021 0.23 0.047 0.003 0.001 0.297 0.082 
83 0 0.232 0.06 0.003 0 0.369 0 
84 0.006 0.186 0.026 0.006 0.002 0.296 0.068 
85 0.001 0.238 0.082 0.002 0.001 0.267 0.079 
86 0.004 0.235 0.006 0.002 0.001 0.274 0.098 
87 0.143 0.225 0.025 0.19 0.14 0.218 0.061 
88 0.024 0.178 0.022 0.003 0.001 0.245 0.091 
89 0.041 0.231 0.004 0.573 0.043 0.23 0.005 
90 0.004 0.258 0.078 0.005 0.002 0.273 0.096 
91 0.001 0.233 0.081 0.005 0.004 0.281 0.081 
92 0.05 0.223 0.044 0.006 0.002 0.288 0.065 
93 0.008 0.173 0.004 0.004 0.001 0.244 0.044 
94 3.044 0.21 0.086 0.104 0.011 0.244 0.01 
95 0.002 0.242 0.119 0.003 0.001 0.254 0.094 
96 0.007 0.211 0.01 0.087 0.004 0.217 0.007 
97 0.115 0.023 0.168 0 0.004 0.001 0.278 
98 0.017 0.224 0.011 0.405 0.015 0.223 0.004 
99 0.013 0.232 0.005 0.031 0.005 0.234 0.014 
100 3.147 0.269 0.061 0.142 0.014 0.213 0.002 
 
 
 
 
 
 
